Secondary Logo

Journal Logo

Current World Literature

doi: 10.1097/MOP.0b013e32835d4b1c
CURRENT WORLD LITERATURE: Bibliography
Free

This bibliography is compiled by clinicians from the relevant journals scanned by this publication. It is based on the literature regularly pulled into our database from OvidSP (articles are generally added to the database about two and a half months after publication). In addition, the bibliography contains every paper annotated by reviewers; these references were obtained from a variety of bibliographic databases and published between the beginning of the review period and the time of going to press. The bibliography has been grouped into topics that relate to the reviews in this issue.

▪ Papers considered by the reviewers to be of special interest

▪▪ Papers considered by the reviewers to be of outstanding interest

The number in square brackets following a selected paper, e.g. [7], refers to its number in the annotated references of the corresponding review.

Back to Top | Article Outline

Hematology and oncology

Global challenges in pediatric oncology

Review: (pp. 3–15)

Baysson H, Etard C, Brisse HJ, Bernier MO. Diagnostic radiation exposure in children and cancer risk: Current knowledge and perspectives. Arch Pediatr 2012; 19:64–73.

▪▪. Beaulieu N, Bloom D, Bloom R, Stein R. Breakaway: the global burden of cancer – challenges and opportunities. A report from the Economist Intelligence Unit, 2009. http://livestrongblog.org/GlobalEconomicImpact.pdf. [03]

▪▪. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 2012; 13:790–801. [14]

▪. Chow EJ, Puumala SE, Mueller BA, et al. Childhood cancer in relation to parental race and ethnicity. Cancer 2010; 116:3045–3053. [16]

de Vries MC, Houtlosser M, Wit JM, Engberts DP, et al. Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences - art. no. 18. BMC Med Ethics 2011; 12:27.

▪. Delgado E, Barfield RC, Baker JN, et al. Availability of palliative care services for children with cancer in economically diverse regions of the world. Eur J Cancer 2010; 46:2260–2266. [53]

▪. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010; 376:1186–1193. [02]

Gamble LD, Kees UR, Tweddle DA, Lunec J. MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63. Oncogene 2012; 31:752–763.

▪. Gupta S, Antillon FA, Bonilla M, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011; 117:4788–4795. [42]

▪▪. Hunger SP, Sung L, Howard SC. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: a proposal. Pediatr Blood Cancer 2009; 52:559–565. [62]

▪. Mostert S, Arora RS, Arreola M, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol 2011; 12:719–720. [31]

▪▪. Needleman J, Buerhaus P, Pankratz VS, et al. Nurse staffing and inpatient hospital mortality. N Engl J Med 2011; 364:1037–1045. [48]

▪▪. No Authors Given. World Health Organization. Blood safety and availability. http://http://www.who.int/mediacentre/factsheets/fs279/en/index.html. [47]

▪▪. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008; 9:721–729. [07]

▪. Sala A, Rossi E, Antillon F, et al. Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer 2012; 48:243–252. [38]

Stefan DC, Harford J, Stones D, Newton R, et al. Hope for African children with cancer: African pediatric oncology group. Pediatr Blood Cancer 2012; 59:349.

▪. Valsecchi MG, Steliarova-Foucher E. Cancer registration in developing countries: luxury or necessity? Lancet Oncol 2008; 9:159–167. [10]

▪. Wilimas JA, Wilson MW, Haik BG, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer 2009; 53:42–46. [73]

▪▪. Xu H, Cheng C, Devidas M, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 2012; 30:751–757. [19]

Back to Top | Article Outline

Childhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects

Review: (pp. 16–22)

▪. Armstrong GT, Liu W, Leisenring W, et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2011; 29:3056–3064. [15]

▪. Armstrong GT, Plana JC, Zhang N, et al. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol 2012; 30:2876–2884. [33]

Barakat LP, Schwartz LA, Szabo MM, Hussey HM, et al. Factors that contribute to post-treatment follow-up care for survivors of childhood cancer. J Cancer Surviv-Res Pract 2012; 6:155–162.

▪▪. Best T, Li D, Skol AD, et al. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin lymphoma. Nat Med 2012; 17:941–943. [18]

▪▪. Blanco JG, Sun CL, Landier W, et al. Anthracycline-Related Cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes: a report from the Children's Oncology Group. J Clin Oncol 2012; 30:1415–1421. [26]

Castellino SM, Tooze JA, Flowers L, Parsons SK. The peabody picture vocabulary test as a pre-screening tool for global cognitive functioning in childhood brain tumor survivors. J Neuro-Oncol 2011; 104:559–563.

Eshelman-Kent D, Kinahan KE, Hobbie W, Landier W, et al. Cancer survivorship practices, services, and delivery: a report from the Children's Oncology Group (COG) nursing discipline, adolescent/young adult, and late effects committees. J Cancer Surviv-Res Pract 2011; 5:345–357.

▪. Fallah-Rad N, Walker JR, Wassef A, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 2011; 57:2263–2270. [34]

▪. Henderson TO, Oeffinger KC, Whitton J, et al. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Ann Intern Med 2012; 156:757–766. [17]

Hildenbrand AK, Clawson KJ, Alderfer MA, Marsac ML. Coping With Pediatric Cancer: Strategies Employed by Children and Their Parents to Manage Cancer-Related Stressors During Treatment. J Pediatr Oncol Nurs 2011; 28:344–354.

Hockenberry MJ, Hooke MC, McCarthy K, Gregurich MA. Sickness Behavior Clustering in Children With Cancer. J Pediatr Oncol Nurs 2011; 28:263–272.

▪. Kirchhoff AC, Krull KR, Ness KK, et al. Physical, mental, and neurocognitive status and employment outcomes in the childhood cancer survivor study cohort. Cancer Epidemiol Biomarkers Prev 2011; 20:1838–1849. [51]

Klassen A, Gulati S, Dix D. Health Care Providers' Perspectives About Working With Parents of Children With Cancer: A Qualitative Study. J Pediatr Oncol Nurs 2012; 29:92–97.

▪. Krull KR, Annett RD, Pan Z, et al. Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer 2011; 47:1380–1388. [52]

Kryh H, Abrahamsson J, Jegeras E, Sjoberg RM, et al. MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastoma. Int J Oncol 2011; 39:1063–1071.

Moules NJ, McCaffrey G, Laing CM, Tapp DM, et al. Grandparents' Experiences of Childhood Cancer, Part 2: The Need for Support. J Pediatr Oncol Nurs 2012; 29:133–140.

Nagai A, Zou N, Kubota M, Kojima C, et al. Fatigue in survivors of childhood acute lymphoblastic and myeloid leukemia in Japan. Pediatr Int 2012; 54:272–276.

▪. Nottage K, McFarlane J, Krasin MJ, et al. Secondary colorectal carcinoma after childhood cancer. J Clin Oncol 2012; 30:2552–2558. [16]

▪. Oudin C, Simeoni MC, Sirvent N, et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 2011; 117:4442–4448. [38]

▪. Patterson BC, Wasilewski-Masker K, Ryerson AB, et al. Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program. J Clin Endocrinol Metab 2012; 97:810–818. [36]

Patterson BC, Wasilewski-Masker K, Ryerson AB, Mertens A, et al. Endocrine Health Problems Detected in 519 Patients Evaluated in a Pediatric Cancer Survivor Program. J Clin Endocrinol Metab 2012; 97:810–818.

▪▪. Polgreen LE, Petryk A, Dietz AC, et al. Modifiable risk factors associated with bone deficits in childhood cancer survivors. BMC Pediatr 2012; 12:40. [44]

Prasad PK, Signorello LB, Friedman DL, Boice JD, et al. Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatr Blood Cancer 2012; 58:421–427.

Quinn GP, Knapp C, Murphy D, Sawczyn K, et al. Congruence of Reproductive Concerns Among Adolescents With Cancer and Parents: Pilot Testing an Adapted Instrument. Pediatrics 2012; 129:E930–E936.

▪▪. Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011; 305:2311–2319. [11]

Shen M, Gong FM, Pang PF, Zhu KS, et al. An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma. Int J Nanomed3319; 7:3319–3332.

▪. Steinberger J, Sinaiko AR, Kelly AS, et al. Cardiovascular risk and insulin resistance in childhood cancer survivors. J Pediatr 2011; 160:494–499. [40]

Stenger C, Naves T, Verdier M, Ratinaud MH. The cell death response to the ROS inducer, cobalt chloride, in neuroblastoma cell lines according to p53 status. Int J Oncol 2011; 39:601–609.

Tencomnao T, Klangthong K, Pimpha N, Chaleawlert-Umpon S, et al. Acceleration of gene transfection efficiency in neuroblastoma cells through polyethyleneimine/poly (methyl methacrylate) core-shell magnetic nanoparticles. Int J Nanomed 2783; 7:2783–2792.

▪▪. van der Pal HJ, van Dalen EC, van Delden E, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol 2012; 30:1429–1437. [23]

▪▪. Visscher H, Ross CJ, Rassekh SR, et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol 2012; 30:1422–1428. [27]

Watanabe T, Matsubara S, Saito Y, Usui R, et al. Pregnant woman with an extremely small uterus due to pelvic irradiation in childhood. J Obstet Gynaecol Res 2012; 38:559–561.

Wessel T, Balcerek M, Reinmuth S, Hohmann C, et al. Age at Menarche in Childhood Cancer Survivors: Results of a Nationwide Survey in Germany. Horm Res Paediatr 2012; 77:108–114.

▪. Wilson CL, Dilley K, Ness KK, et al. Fractures among long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 2012. [Epub ahead of print] [42]

Yagci-Kupeli B, Akyuz C, Kupeli S, Buyukpamukcu M. Health-related Quality of Life in Pediatric Cancer Survivors: A Multifactorial Assessment Including Parental Factors. J Pediatr Hematol Oncol 2012; 34:194–199.

Back to Top | Article Outline

New developments in the treatment of pediatric hemophilia and bleeding disorders

Review: (pp. 23–30)

Alesci RS, Krekeler S, Seifried E, Miesbach W. Do patients with haemophilia and von Willebrand disease with arterial hypertension have bleeding complications: a German single centre cohort. Blood Coagul Fibrinolysis 2012; 23:320–323.

Alexander M, Barnes C, Barnett P. Prospective audit of patients with haemophilia: Bleeding episodes and management. J Paediatr Child Health 2012; 48:177–179.

Baker JR, Riske B, Voutsis M, Cutter S, et al. Insurance, Home Therapy, and Prophylaxis in US Youth with Severe Hemophilia. Am J Prev Med 2011; 41:S338–S345.

Balak DMW, Gouw SC, Plug I, Mauser-Bunschoten EP, et al. Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands. Haemophilia 2012; 18:584–592.

Barillari G, Pasca S, Erice F, Livi U. Successful double bypass in a patient with severe hemophilia A: a case report. J Thromb Thrombolysis 2012; 33:193–196.

Berntorp E, Halimeh S, Gringeri A, Mathias M, et al. Management of bleeding disorders in children. Haemophilia 2012; 18:15–23.

Bowyer AE, Goodeve A, Liesner R, Mumford AD, et al. p.Tyr365Cys change in factor VIII: haemophilia A, but not as we know it. Br J Haematol 2011; 154:618–625.

Castaman G, Giacomelli SH, Mancuso ME, D'Andrea G, et al. Deep intronic variations may cause mild hemophilia A. J Thromb Haemost 2011; 9:1541–1548.

Chitlur M. Challenges in the laboratory analyses of bleeding disorders. Thromb Res 2012; 130:1–6.

Chuah MK, Nair N, Van den Driessche T. Recent Progress in Gene Therapy for Hemophilia. Hum Gene Ther 2012; 23:557–565.

Coppola A, Favaloro EJ, Tufano A, Di Minno MND, et al. Acquired Inhibitors of Coagulation Factors: Part I-Acquired Hemophilia A. Semin Thromb Hemost 2012; 38:433–446.

▪▪. Coppola A, Favaloro EJ, Tufano A, et al. Acquired inhibitors of coagulation factors. Part I – Acquired hemophilia A. Semin Thromb Hemost 2012; 38:433–446. [03]

de Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, et al. Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease. Thromb Haemost 2011; 106:885–892.

Faridi NJ, Husain N, Siddiqi MI, Kumar P, et al. Identification of Missense Mutations in Exon 16 of Factor VIII Gene in Mild and Moderate Cases With Hemophilia A. Clin Appl Thromb-Hemost 2011; 17:358–361.

Favaloro EJ. von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding Disorder. Semin Thromb Hemost 2011; 37:440–455.

Fijnvandraat K, Cnossen MH, Leebeek FWG, Peters M. Diagnosis and management of haemophilia - art. no. e2707. Br Med J2707; 344:2.

Fowler H, Lacey R, Keaney J, Kay-Jones C, et al. Emergency and out of hours care of patients with inherited bleeding disorders. Haemophilia 2012; 18:e126–e131.

Franchini M, Lippi G, Favaloro EJ. Acquired Inhibitors of Coagulation Factors: Part II. Semin Thromb Hemost 2012; 38:447–453.

Gater A, Thomson TA, Strandberg-Larsen M. Haemophilia B: impact on patients and economic burden of disease. Thromb Haemost 2011; 106:398–404.

Ghosh K, Shetty S. Epidemiology, Diagnosis, and Management of von Willebrand Disease in India. Semin Thromb Hemost 2011; 37:595–601.

Iorio A, Marchesini E, Marcucci M, Stobart K, et al. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B - art. no. CD003429. Cochrane Database Syst Rev 2011;3429.

▪▪. Ivanciu L, Toso R, Margaritis P, et al. A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia. Nat Biotechnol 2011; 29:1028–1033. [18]

James PD, Lillicrap DP. The Diagnosis and Management of von Willebrand Disease in Canada. Semin Thromb Hemost 2011; 37:522–527.

Keeney S, Collins P, Cumming A, Goodeve A, et al. Diagnosis and Management of von Willebrand Disease in the United Kingdom. Semin Thromb Hemost 2011; 37:488–494.

Kemkes-Matthes B, Heidinger K, Kirsch-Altena A, Fischer R. Hemorrhagic disorders. Internist 2012; 53:833–842.

Knoebl P, Marco P, Baudo F, Collins P, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 2012; 10:622–631.

Kulkarni R, Soucie JM. Pediatric Hemophilia: A Review. Semin Thromb Hemost 2011; 37:737–744.

Lassila R, Holme PA, Landorph A, Petrini P, et al. Nordic Haemophilia Council's Practical Guidelines on Diagnosis and Management of von Willebrand Disease. Semin Thromb Hemost 2011; 37:495–502.

Lautz TB, Naiditch JA, Clark S, Chu F, et al. Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma. J Pediatr Surg 2012; 47:1267–1271.

Lippi G, Franchini M, Montagnana M, Favaloro EJ. Inherited disorders of blood coagulation. Ann Med 2012; 44:405–418.

Madoiwa S, Kobayashi E, Kashiwakura Y, Sakata A, et al. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice. Haemophilia 2012; 18:e323–e330.

Mahendra A, Padiolleau-Lefevre S, Kaveri SV, Lacroix-Desmazes S. Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A? Br J Haematol 2012; 156:3–12.

▪. Mannucci PM, Mancuso ME, Santagostino E. How we choose factor VIII to treat hemophilia? Blood 2012; 119:4108–4114. [12]

Massaro JD, Wiezel CEV, Muniz YCN, Rego EM, et al. Analysis of five polymorphic DNA markers for indirect genetic diagnosis of haemophilia A in the Brazilian population. Haemophilia 2011; 17:E936–E943.

Matsushita K, Uchida K, Saigusa S, Ide S, et al. Glycolysis inhibitors as a potential therapeutic option to treat aggressive neuroblastoma expressing GLUT1. J Pediatr Surg 2012; 47:1323–1330.

Mazzeffi MA, Stone ME. Perioperative management of von Willebrand disease: a review for the anesthesiologist. J Clin Anesth 2011; 23:418–426.

▪. Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 2011; 12:341–355. [22]

▪▪. Nathwani AC, Tuddenham EG, Rangarajan S, et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 2011; 365:2357–2365. [23]

Negrier C, Knobe K, Tiede A, Giangrande P, et al. Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B. Blood 2011; 118:2695–2701.

O'Brien SH. An update on pediatric bleeding disorders: Bleeding scores, benign joint hypermobility, and platelet function testing in the evaluation of the child with bleeding symptoms. Am J Hematol 2012; 87:S40–S44.

Ofosu FA, Santagostino E, Grancha S, Marco P. Management of bleeding disorders: basic science. Haemophilia 2012; 18:8–14.

Peltier J, Baroncini M, Thines L, Leteurtre S, et al. Haemophilia A and intracranial bleedings in infants. Neurochirurgie 2012; 58:19–24.

Peyvandi F, Palla R, Menegatti M, Siboni SM, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10:615–621.

Pinto CS, Fidalgo T, Salvado R, Marques D, et al. Molecular diagnosis of haemophilia A at Centro Hospitalar de Coimbra in Portugal: study of 103 families-15 new mutations. Haemophilia 2012; 18:129–138.

Poon MC, Card R. Hemophilia management in transfusion medicine. Transfus Apher Sci 2012; 46:299–307.

Rodgers SE, Lloyd JV, Mangos HM, Duncan EM, et al. Diagnosis and Management of Adult Patients with von Willebrand Disease in South Australia. Semin Thromb Hemost 2011; 37:535–541.

Rushton AR. Leopold: The ‘‘Bleeder Prince’' and Public Knowledge about Hemophilia in Victorian Britain. J Hist Med Allied Sci 2012; 67:457–490.

Saha A, Nayak S, Mani KR, Chandak GR, et al. A set of five microsatellite markers linked to F8 gene can detect haemophilia A carriers across India. Haemophilia 2011; 17:E928–E935.

Scola MR, Baggesen LM, Nichols TC, Key NS, et al. A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach. Thromb Res 2012; 129:S57–S61.

Scola MR, Nichols TC, Zhu HT, Caughey MC, et al. Arfi ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von willebrand disease and hemophilia. Ultrasound Med Biol 2011; 37:2126–2132.

Seary ME, Feldman D, Carcao MD. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype. Haemophilia 2012; 18:50–55.

▪. Sharathkumar AA, Carcao M. Clinical advances in hemophilia management. Pediatr Blood Cancer 2011; 57:910–920. [01]

Skinner MW. Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements. Br J Haematol 2011; 154:704–714.

Sorensen B, Dargaud Y, Kenet G, Lusher J, et al. On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII. Haemophilia 2012; 18:255–262.

Souza JC, Simoes HG, Campbell CSG, Pontes FL, et al. Haemophilia and Exercise. Int J Sports Med 2012; 33:83–88.

Spiezia L, Radu C, Campello E, Bulato C, et al. Whole blood rotation thromboelastometry (ROTEM (R)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. Haemophilia 2012; 18:463–468.

Tan C, Sabai SM, Tin AS, Quah TC, et al. Neuroblastoma: experience from National University Health System, Singapore (1987-2008). Singap Med J 2012; 53:19–25.

Van den Driessche T, Chuah MK. Clinical Progress in Gene Therapy: Sustained Partial Correction of the Bleeding Disorder in Patients Suffering from Severe Hemophilia B. Hum Gene Ther 2012; 23:4–6.

van Herrewegen F, Meijers JCM, Peters M, van Ommen CH. The bleeding child. Part II: Disorders of secondary hemostasis and fibrinolysis. Eur J Pediatr 2012; 171:207–214.

▪. Wong T, Recht M. Current options and new developments in the treatment of haemophilia. Drugs 2011; 71:305–320. [02]

Yadav N, Kanjirakkuzhiyil S, Ramakrishnan M, Das TK, et al. Factor VIII Can Be Synthesized in Hemophilia A Mice Liver by Bone Marrow Progenitor Cell-Derived Hepatocytes and Sinusoidal Endothelial Cells. Stem Cells Dev 2012; 21:110–120.

Back to Top | Article Outline

Perinatal management of infant tumors and the promise of fetal surgery

Review: (pp. 31–39)

▪. Al-Hussein HA, Graham EM, Tekes A, Huisman TA. Pre and postnatal imaging of a congenital hepatoblastoma. Fetal Diagn Ther 2011; 30:157–159. [39]

▪. Gucciardo L, Uyttebroek A, De Wever I, et al. Prental assessment and management of sacrococcygeal teratoma. Prenat Diagn 2011; 31:678–688. [47]

▪. Huang LC, Ho M, Chang WC, et al. Prenatal diagnosis of fetal hepatoblastoma with a good neonatal outcome: case report and narrative literature review. Pediatr Heme Oncol 2011; 28:150–154. [40]

▪. Lee MY, Won HS, Hyun MK, et al. Perinatal outcome of sacrococcygeal teratoma. Prenat Diagn 2011; 31:1217–1221. [51]

▪. Meyers RL, Tiao GM, Dunn SP, Langham Jr MR. Liver transplantation in the management of unresectable hepatoblastoma in children. Front Biosci (Elite Ed) 2012; 4:1293–1302. [41]

▪. Rodriguez MA, Cass DL, Lazar DA, et al. Tumor volume to fetal weight ratio as an early prognostic classification for fetal sacrococcygeal teratoma. J Pediatr Surg 2011; 46:1182–1185. [48]

▪. Roybal JL, Moldenhauer JS, Khalek N, et al. Early delivery as an alternative management strategy for selected high-risk fetal sacrococcygeal teratomas. J Pediatr Surg 2011; 46:1325–1332. [50]

▪. Usua N, Kitano Y, Sago H, et al. Outcomes of prenatally diagnosed sacrococcygeal teratomas: the results of a Japanese nationwide survey. J Pediatr Surg 2012; 47:441–447. [49]

Back to Top | Article Outline

New genetic discoveries and treatments for neuroblastoma

. Progesterone could become potential therapy against neuroblastoma. Future Oncol 2011; 7:1031.

Allen NM, McKeon A, O'Rourke DJ, O'Meara A, et al. Excessive Blinking and Ataxia in a Child With Occult Neuroblastoma and Voltage-Gated Potassium Channel Antibodies. Pediatrics 2012; 129:E1348–E1352.

Atif F, Sayeed I, Yousuf S, Ishrat T, et al. Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence. Mol Med 2011; 17:1084–1094.

Azarova AM, Gautam G, George RE. Emerging importance of ALK in neuroblastoma. Semin Cancer Biol 2011; 21:267–275.

Back L, Oinas M, Pietarinen-Runtti P, Saarilahti K, et al. The developing management of esthesioneuroblastoma: a single institution experience. Eur Arch Oto-Rhino-Laryn 2012; 269:213–221.

Bae SJ, Kang C, Sung KW, Chueh HW, et al. Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma. J Korean Med Sci 2012; 27:363–369.

Bakos J, Strbak V, Ratulovska N, Bacova Z. Effect of Oxytocin on Neuroblastoma Cell Viability and Growth. Cell Mol Neurobiol 2012; 32:891–896.

Bao L, Dunham K, Lucas K. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing. Cancer Immunol Immunother 2011; 60:1299–1307.

Barnes CM, Prox D, Christison-Lagay EA, Le HD, et al. Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib. Pediatr Res 2012; 71:168–178.

Bedo G, Pascual A, Aranda A. Early Thyroid Hormone-induced Gene Expression Changes in N2a-beta Neuroblastoma Cells. J Mol Neurosci 2011; 45:76–86.

Berry T, Luther W, Bhatnagar N, Jamin Y, et al. The ALK(F1174L) Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma. Cancer Cell 2012; 22:117–130.

Besancon OG, Tytgat GAM, Meinsma R, Leen R, et al. Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids. Cancer Lett 2012; 319:23–30.

Bisogno G, Soloni P, Conte M, Podda M, et al. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees - art. no. 117. BMC Cancer 2012; 12:25.

Bochennek K, Esser R, Lehrnbecher T, Glienke W, et al. Impact of Minimal Residual Disease Detection Prior to Autologous Stem Cell Transplantation for Post-transplant Outcome in High Risk Neuroblastoma. Klinische Padiatr 2012; 224:139–142.

Borner C, Martella E, Hollt V, Kraus J. Regulation of Opioid and Cannabinoid Receptor Genes in Human Neuroblastoma and T Cells by the Epigenetic Modifiers Trichostatin A and 5-Aza-2 '-Deoxycytidine. Neuroimmunomodulation 2012; 19:180–186.

Bull VH, Rajalingam K, Thiede B. Sorafenib-Induced Mitochondrial Complex I Inactivation and Cell Death in Human Neuroblastoma Cells. J Proteome Res 2012; 11:1609–1620.

Carpenter EL, Mosse YP. Targeting ALK in neuroblastoma-preclinical and clinical advancements. Nat Rev Clin Oncol 2012; 9:391–399.

Chakrabarti M, Khandkar M, Banik NL, Ray PK. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells. Brain Res1454:15.

Chang CY, Ma KH, Wang JK, Tung YL, et al. Inhibition of protein kinase C promotes differentiation of neuroblastoma x glioma NG108-15 hybrid cells. Eur J Neurosci 2011; 34:1074–1084.

Charlet J, Schnekenburger M, Brown KW, Diederich M. DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs. Biochem Pharmacol 2012; 83:858–865.

Chen ST, Jeng YM, Chang CC, Chang HH, et al. Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma. Cancer Sci 2011; 102:2191–2198.

Chen YH, Yeh CW, Lo HC, Su SL, et al. Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cells. Oncol Rep 2012; 27:1233–1237.

Chesler L, Weiss WA. Genetically engineered murine models - Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma. Semin Cancer Biol 2011; 21:245–255.

Choi JS, Shin HY, Kwon KS, Shin S, et al. Effects of Oxypeucedanin on Global Gene Expression and MAPK Signaling Pathway in Mouse Neuroblastoma Neuro-2A Cells. Planta Med 2011; 77:1512–1518.

Chonpathompikunlert P, Yoshitomi T, Han J, Isoda H, et al. The use of nitroxide radical-containing nanoparticles coupled with piperine to protect neuroblastoma SH-SY5Y cells from A beta-induced oxidative stress. Biomaterials 2011; 32:8605–8612.

Chuang JH, Chuang HC, Huang CC, Wu CL, et al. Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells - art. no. 65. J Biomed Sci 2011; 18:23.

Cole KA, Maris JM. New Strategies in Refractory and Recurrent Neuroblastoma: Translational Opportunities to Impact Patient Outcome. Clin Cancer Res 2012; 18:2423–2428.

Condello S, Calabro E, Caccamo D, Curro M, et al. Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: Fourier transform infrared spectroscopy analysis in a model of Parkinson's disease. Amino Acids 2012; 42:775–781.

Cournoyer S, Nyalendo C, Addioui A, Belounis A, et al. Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma. Gene Chromosomes Cancer 2012; 51:792–804.

Couzin-Frankel J. PERSONALIZED MEDICINE Pushing the Envelope in Neuroblastoma Therapy. Science 2011; 333:1569–1571.

Cuperus R, van Kuilenburg ABP, Leen R, Bras J, et al. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids. Free Radic Biol Med 2011; 51:1213–1220.

D'Aguanno S, D'Agnano I, De Canio M, Rossi C, et al. Shotgun proteomics and network analysis of neuroblastoma cell lines treated with curcumin. Mol Biosyst 2012; 8:1068–1077.

Das S, Rao BN, Rao BSS. Mangiferin attenuates methylmercury induced cytotoxicity against IMR-32, human neuroblastoma cells by the inhibition of oxidative stress and free radical scavenging potential. Chem-Biol Interact 2011; 193:129–140.

Davenport KP, Blanco FC, Sandler AD. Pediatric Malignancies Neuroblastoma, Wilm's Tumor, Hepatoblastoma, Rhabdomyosarcoma, and Sacroccygeal Teratoma. Surg Clin-North Am 2012; 92:745.

Davidoff AM. Neuroblastoma. Semin Pediatr Surg 2012; 21:2–14.

Davis W. The ATP-binding cassette transporter-2 (ABCA2) regulates cholesterol homeostasis and low-density lipoprotein receptor metabolism in N2a neuroblastoma cells. Biochim Biophys Acta Mol Cell Biol Lipids 2011; 1811:1152–1164.

De Preter K, Mestdagh P, Vermeulen J, Zeka F, et al. miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples. Clin Cancer Res 2011; 17:7684–7692.

Del Grosso F, De Mariano M, Passoni L, Luksch R, et al. Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines - art. no. 525. BMC Cancer 2011; 11:22.

Di Francesco AM, Ubezio P, Torella AR, Meco D, et al. Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models. Invest New Drugs 2012; 30:1319–1330.

Dickey A, Schleicher S, Leahy K, Hu R, et al. GSK-3 beta inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line. J Neuro-Oncol 2011; 104:145–153.

Du BY, Song W, Bai L, Shen Y, et al. Synergistic Effects of Combination Treatment with Bortezomib and Doxorubicin in Human Neuroblastoma Cell Lines. Chemotherapy 2012; 58:44–51.

Du Bois SG, Chesler L, Groshen S, Hawkins R, et al. Phase I Study of Vincristine, Irinotecan, and I-131-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial. Clin Cancer Res 2012; 18:2679–2686.

Duijkers FAM, Gaal J, Meijerink JPP, Admiraal P, et al. Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels. Cell Oncol 2011; 34:409–417.

Duijkers FAM, Gaal J, Meijerink JPP, Admiraal P, et al. High Anaplastic Lymphoma Kinase Immunohistochemical Staining in Neuroblastoma and Ganglioneuroblastoma Is an Independent Predictor of Poor Outcome. Am J Pathol 2012; 180:1223–1231.

Egler RA, Li YT, Dang TAT, Peters TL, et al. An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring. Proteom Clin Appl 2011; 5:532–541.

Faisal A, Vaughan L, Bavetsias V, Sun CB, et al. The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo. Mol Cancer Ther 2011; 10:2115–2123.

Fieuw A, Kumps C, Schramm A, Pattyn F, et al. Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas. Int J Cancer 2012; 130:2599–2606.

Filomeni G, Piccirillo S, Rotilio G, Ciriolo MR. p38(MAPK) and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y. Biochem Pharmacol 2012; 83:1349–1357.

Fisher JPH, Tweddle DA. Neonatal neuroblastoma. Semin Fetal Neonatal Med 2012; 17:207–215.

Francisco R, Perez-Perarnau A, Cortes C, Gil J, et al. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. Cancer Lett 2012; 318:42–52.

Fung WN, Hasan MY, Loh AHP, Chua JHY, et al. Gene Expression of TRK Neurotrophin Receptors in Advanced Neuroblastomas in Singapore-A Pilot Study. Pediatr Hematol Oncol 2011; 28:571–578.

Furfaro AL, Macay JRZ, Marengo B, Nitti M, et al. Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1. Free Radic Biol Med 2012; 52:488–496.

Gamble LD, Kees UR, Tweddle DA, Lunec J. MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63. Oncogene 2012; 31:752–763.

Gao QG, Xie JX, Wong MS, Chen WF. IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells. Eur J Pharmacol 2012; 677:39–46.

Gatsinzi T, Iverfeldt K. Sensitization to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by NF-kappa B inhibitors is dependent on reactive oxygen species (ROS). J Neuro-Oncol 2011; 104:459–472.

Geiger K, Hagenbuchner J, Rupp M, Fiegl H, et al. FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma. Mol Biol Cell 2012; 23:2226–2234.

Geoerger B, Kieran MW, Grupp S, Perek D, et al. Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma. Eur J Cancer 2012; 48:253–262.

Giorgi G, Marcantonio P, Del Re B. LINE-1 retrotransposition in human neuroblastoma cells is affected by oxidative stress. Cell Tissue Res 2011; 346:383–391.

Gowda M, Godder K, Kmieciak M, Worschech A, et al. Distinct signatures of the immune responses in low risk versus high risk neuroblastoma - art. no. 170. J Transl Med 2011; 9:6.

Grupp SA, Asgharzadeh S, Yanik GA. Neuroblastoma: Issues in Transplantation. Biol Blood Marrow Transplant 2012; 18:S92–S100.

Gustafson WC, Matthay KK. Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma. Expert Rev Neurother 2011; 11:1411–1423.

Hattangadi JA, Rombi B, Yock TI, Broussard G, et al. Proton Radiotherapy for High-Risk Pediatric Neuroblastoma: Early Outcomes and Dose Comparison. Int J Radiat Oncol Biol Phys 2012; 83:1015–1022.

Hatziagapiou K, Braoudaki M, Karpusas M, Tzortzatou-Stathopoulou F. Evaluation of Antitumor activity of Gefitinib in Pediatric Glioblastoma and Neuroblastoma Cells. Clin Lab 2011; 57:781–784.

Hayashi M, Okabe K, Kato K, Okumura M, et al. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett 2012; 316:91–96.

Hiyoshi H, Abdelhady S, Segerstrom L, Sveinbjornsson B, et al. Quiescence and gamma H2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase. Br J Cancer 2012; 106:1807–1815.

Hossain MM, Banik NL, Ray SK. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Exp Cell Res 2012; 318:1597–1610.

Iehara T, Hiyama E, Tajiri T, Yoneda A, et al. Is the prognosis of stage 4 s neuroblastoma in patients 12 months of age and older really excellent? Eur J Cancer 2012; 48:1707–1712.

Ivanov VN, Hei TK. Regulation of apoptosis in human melanoma and neuroblastoma cells by statins, sodium arsenite and TRAIL: a role of combined treatment versus monotherapy. Apoptosis 2011; 16:1268–1284.

Jeison M, Yaniv I, Ash S. Genetic stratification of neuroblastoma for treatment tailoring. Future Oncol 2011; 7:1087–1099.

Jiao PF, Zhou HY, Otto M, Mu QX, et al. Leading Neuroblastoma Cells To Die by Multiple Premeditated Attacks from a Multifunctionalized Nanoconstruct. J Am Chem Soc 2011; 133:13918–13921.

Johnson K, McGlynn B, Saggio J, Baniewicz D, et al. Safety and Efficacy of Tandem I-131-Metaiodobenzylguanidine Infusions in Relapsed/Refractory Neuroblastoma. Pediatr Blood Cancer 2011; 57:1124–1129.

Kamijo T. Role of sternness-related molecules in neuroblastoma. Pediatr Res 2012; 71:511–515.

Keim A, Rossler OG, Rothhaar TL, Thiel G. Arsenite-induced apoptosis of human neuroblastoma cells requires p53 but occurs independently of c-jun. Neuroscience 2012; 206:25–38.

Kitano T, Yoda H, Tabata K, Miura M, et al. Vitamin K3 Analogs Induce Selective Tumor Cytotoxicity in Neuroblastoma. Biol Pharm Bull 2012; 35:617–623.

Klymenko T, Brandenburg M, Morrow C, Dive C, et al. The Novel Bcl-2 Inhibitor ABT-737 Is More Effective in Hypoxia and Is Able to Reverse Hypoxia-Induced Drug Resistance in Neuroblastoma Cells. Mol Cancer Ther 2011; 10:2373–2383.

Kondo N, Takahashi H, Nii Y, Nagao J. Olfactory Neuroblastoma: 15 Years of Experience. Anticancer Res 2012; 32:1697–1703.

Kosmin MA, Bomanji JB, Cork NJ, Shankar A, et al. Hypertension complicating I-131-meta-iodobenzylguanidine therapy for neuroblastoma. Eur J Nucl Med Mol Imaging 2012; 39:597–601.

Kounami S, Nakayama K, Yoshiyama M, Rikoh M, et al. Early-Onset Hemophagocytic Lymphohistiocytosis after the Start of Chemotherapy for Advanced Neuroblastoma. Pediatr Hematol Oncol 2012; 29:99–103.

Kuroda T. Cellular kinetics of neuroblastoma and the role of surgery. Pediatr Surg Int 2011; 27:913–917.

Kwon MJ, Choi YL, Sung KW, Kang SY, et al. Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors. Pathol Res Pract 2011; 207:634–639.

Lamers F, Schild L, Koster J, Versteeg R, et al. Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression. Eur J Cancer 2012; 48:763–771.

Lamers F, van der Ploeg I, Schild L, Ebus ME, et al. Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe. Endocr-Relat Cancer 2011; 18:657–668.

Lautz TB, Naiditch JA, Clark S, Chu F, et al. Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma. J Pediatr Surg 2012; 47:1267–1271.

Levy AG, Zage PE, Akers LJ, Ghisoli ML, et al. The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma. Invest New Drugs 2012; 30:191–199.

Li K, Dong KR, Gao JC, Yao W, et al. Neuroblastoma Management in Chinese Children. J Invest Surg 2012; 25:86–92.

Li N, He YY, Wang L, Mo CF, et al. D-Galactose Induces Necroptotic Cell Death in Neuroblastoma Cell Lines. J Cell Biochem 2011; 112:3834–3844.

Li ZJ, Oh DY, Nakamura K, Thiele CJ. Perifosine-induced inhibition of akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo. Cancer 2011; 117:5412–5422.

Light JE, Koyama H, Minturn JE, Ho R, et al. Clinical significance of NTRK family gene expression in neuroblastomas. Pediatr Blood Cancer 2012; 59:226–232.

Lin JW, Chen JT, Hong CY, Lin YL, et al. Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway. Neuro-Oncology 2012; 14:302–314.

Liu HB, Jiang CY, Xiong CM, Ruan JL. DEDC, a new flavonoid induces apoptosis via a ROS-dependent mechanism in human neuroblastoma SH-SYSY cells. Toxicol Vitro 2012; 26:16–23.

Manor E, Kapelushnik J, Joshua BZ, Bodner L. Metastatic neuroblastoma of the mandible: a cytogenetic and molecular genetic study. Eur Arch Oto-Rhino-Laryn 2012; 269:1967–1971.

Martinez MA, Ubeda A, Cid MA, Trillo MA. The Proliferative Response of NB69 Human Neuroblastoma Cells to a 50 Hz Magnetic Field is mediated by ERK1/2 Signaling. Cell Physiol Biochem 2012; 29:675–686.

Marzinke MA, Clagett-Dame M. The all-trans retinoic acid (atRA)-regulated gene Calmin (Clmn) regulates cell cycle exit and neurite outgrowth in murine neuroblastoma (Neuro2a) cells. Exp Cell Res 2012; 318:85–93.

Matsushita K, Uchida K, Saigusa S, Ide S, et al. Glycolysis inhibitors as a potential therapeutic option to treat aggressive neuroblastoma expressing GLUT1. J Pediatr Surg 2012; 47:1323–1330.

Matthay KK, George RE, Yu AL. Promising Therapeutic Targets in Neuroblastoma. Clin Cancer Res 2012; 18:2740–2753.

Mei Y, Wang ZX, Zhang L, Zhang YR, et al. Regulation of neuroblastoma differentiation by forkhead transcription factors FOXO1/3/4 through the receptor tyrosine kinase PDGFRA. Proc Natl Acad Sci U S A 2012; 109:4898–4903.

Michaelis M, Hinsch N, Michaelis UR, Rothweiler F, et al. Chemotherapy-Associated Angiogenesis in Neuroblastoma Tumors. Am J Pathol 2012; 180:1370–1377.

Minturn JE, Evans AE, Villablanca JG, Yanik GA, et al. Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study. Cancer Chemother Pharmacol 2011; 68:1057–1065.

Modak S, Cheung IY, Kushner BH, Kramer K, et al. Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma. Pediatr Blood Cancer 2012; 58:469–471.

Mohan N, Banik NL, Ray SK. Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells. Neurosci Lett 2011; 502:24–29.

Monnereau-Laborde S, Munzer C, Valteau-Couanet D, Ansoborlo S, et al. A Dose-Intensive Approach (NB96) for Induction Therapy Utilizing Sequential High-Dose Chemotherapy and Stem Cell Rescue in High-Risk Neuroblastoma in Children Over 1 Year of Age. Pediatr Blood Cancer 2011; 57:965–971.

Muroi Y, Ishii T. Umami taste receptor functions as an amino acid sensor via Gas subunit in N1E-115 neuroblastoma cells. J Cell Biochem 2012; 113:1654–1662.

Nakagawa A, Matsuoka K, Okita H, Iwafuchi H, et al. Neuroblastomas with Discordant Genotype-Phenotype Relationships: Report of Four Cases with MYCN Amplification and Favorable Histology. Pediatr Dev Pathol 2011; 14:87–92.

Nelson NJ. Targeting the Right Treatments for Neuroblastoma. J Natl Cancer Inst 2011; 103:1218–1221.

Niewisch MR, Kuci Z, Wolburg H, Sautter M, et al. Influence of Dichloroacetate (DCA) on Lactate Production and Oxygen Consumption in Neuroblastoma Cells: Is DCA a Suitable Drug for Neuroblastoma Therapy? Cell Physiol Biochem 2012; 29:373–380.

Nukuzuma S, Kameoka M, Sugiura S, Nakamichi K, et al. Exogenous human immunodeficiency virus-1 protein, tat, enhances replication of JC virus efficiently in neuroblastoma cell lines. J Med Virol 2012; 84:555–561.

Oguma M, Morimoto A, Takada A, Kashii Y, et al. Another promising treatment option for neuroblastoma-associated opsoclonus-myoclonus syndrome by oral high-dose dexamethasone pulse: Lymphocyte markers as disease activity. Brain Dev 2012; 34:251–254.

Ooi WF, Re A, Sidarovich V, Canella V, et al. Segmental chromosome aberrations converge on overexpression of mitotic spindle regulatory genes in high-risk neuroblastoma. Gene Chromosomes Cancer 2012; 51:545–556.

Ora I, Eggert A. Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research. Semin Cancer Biol 2011; 21:217–228.

Orr WS, Denbo JW, Saab KR, Myers AL, et al. Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition. Surgery 2012; 151:736–744.

Osera C, Fassina L, Amadio M, Venturini L, et al. Cytoprotective Response Induced by Electromagnetic Stimulation on SH-SY5Y Human Neuroblastoma Cell Line. Tissue Eng Part A: Part A 2011; 17:2573–2582.

Owens C, Irwin M. Neuroblastoma: The impact of biology and cooperation leading to personalized treatments. Crit Rev Clin Lab Sci 2012; 49:85–115.

Park JR, Scott JR, Stewart CF, London WB, et al. Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study. J Clin Oncol 2011; 29:4351–4357.

Polishchuk AL, Du Bois SG, Haas-Kogan D, Hawkins R, et al. Response, Survival, and Toxicity After Iodine-131-Metaiodobenzylguanidine Therapy for Neuroblastoma in Preadolescents, Adolescents, and Adults. Cancer 2011; 117:4286–4293.

Poretti A, Grotzer MA. Neuroblastoma with spinal cord compression: is there an emergency treatment of choice? Dev Med Child Neurol 2012; 54:297–298.

Prochazka P, Libra A, Zemanova Z, Hrebackova J, et al. Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells. Cancer Sci 2012; 103:334–341.

Qayed M, Chiang KY, Ricketts R, Alazraki A, et al. Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma. Pediatr Blood Cancer 2012; 58:448–452.

Qureshi SS, Patil VP. Feasibility and safety of thoracoabdominal approach in children for resection of upper abdominal neuroblastoma. J Pediatr Surg 2012; 47:694–699.

Radi M, Brullo C, Crespan E, Tintori C, et al. Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells. Bioorg Med Chem Lett 2011; 21:5928–5933.

Rodriguez-Milla MA, Mirones I, Marinas-Pardo L, Melen GJ, et al. Enrichment of neural-related genes in human mesenchymal stem cells from neuroblastoma patients. Int J Mol Med 2012; 30:365–373.

Saito H, Tabata K, Hanada S, Kanda Y, et al. Synthesis of methoxy- and bromo-substituted indirubins and their activities on apoptosis induction in human neuroblastoma cells. Bioorg Med Chem Lett 2011; 21:5370–5373.

Sakane C, Shidoji Y. Reversible upregulation of tropomyosin-related kinase receptor B by geranylgeranoic acid in human neuroblastoma SH-SY5Y cells. J Neuro-Oncol 2011; 104:705–713.

Santana S, Recuero M, Bullido MJ, Valdivieso F, et al. Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells - art. no. 430.e19. Neurobiol Aging 2012; 33:E19.

Sartelet H, Imbriglio T, Nyalendo C, Haddad E, et al. CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Histopathology 2012; 60:1144–1155.

Sartelet H, Rougemont AL, Fabre M, Castaing M, et al. Activation of the phosphatidylinositol 3 '-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1. Hum Pathol 2011; 42:1727–1739.

Schiapparelli P, Shahi MH, Enguita-German M, Johnsen JI, et al. Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+cell compartment and the in vitro tumorigenic capability of neuroblastoma cells. Cancer Lett 2011; 310:222–231.

Schleiermacher G, Michon J, Ribeiro A, Pierron G, et al. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer 2011; 105:1940–1948.

Seeger RC. Immunology and immunotherapy of neuroblastoma. Semin Cancer Biol 2011; 21:229–237.

Segerstrom L, Baryawno N, Sveinbjornsson B, Wickstrom M, et al. Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo. Int J Cancer 2011; 129:2958–2965.

Sharp SE, Gelfand MJ, Shulkin BL. Pediatrics: Diagnosis of Neuroblastoma. Semin Nucl Med 2011; 41:345–353.

Shin JH, Park SJ, Kim ES, Jo YK, et al. Sertindole, a Potent Antagonist at Dopamine D-2 Receptors, Induces Autophagy by Increasing Reactive Oxygen Species in SH-SY5Y Neuroblastoma Cells. Biol Pharm Bull 2012; 35:1069–1075.

Shukla N, Ameur N, Yilmaz I, Nafa K, et al. Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways. Clin Cancer Res 2012; 18:748–757.

Shusterman S, Grant FD, Lorenzen W, Davis RT, et al. Iodine-131-labeled Meta-Iodobenzylguanidine Therapy of Children with Neuroblastoma: Program Planning and Initial Experience. Semin Nucl Med 2011; 41:354–363.

Simon T, Niemann CA, Hero B, Henze G, et al. Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastoma. Dev Med Child Neurol 2012; 54:347–352.

Singh A, Rokes C, Gireud M, Fletcher S, et al. Retinoic Acid Induces REST Degradation and Neuronal Differentiation by Modulating the Expression of SCF beta-TRCP in Neuroblastoma Cells. Cancer 2011; 117:5189–5202.

Sommer AP, Bieschke J, Friedrich RP, Zhu D, et al. 670 nm Laser Light and EGCG Complementarily Reduce Amyloid-beta Aggregates in Human Neuroblastoma Cells: Basis for Treatment of Alzheimer's Disease? Photomed Laser Surg 2012; 30:54–60.

Sorrentino S, Rosanda C, Parodi S, Gigliotti AR, et al. Cyto-Morphologic Evaluation of Bone Marrow in Infants With Disseminated Neuroblastoma. J Pediatr Hematol Oncol 2012; 34:154–158.

Speleman F, De Preter K, Van desompele J. Neuroblastoma genetics and phenotype: A tale of heterogeneity. Semin Cancer Biol 2011; 21:238–244.

Stutterheim J, Ichou FA, den Ouden E, Versteeg R, et al. Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma. Clin Cancer Res 2012; 18:808–814.

Stutterheim J, Zappeij-Kannegieter L, Ora I, van Sluis PG, et al. Stability of PCR Targets for Monitoring Minimal Residual Disease in Neuroblastoma. J Mol Diagn 2012; 14:168–175.

Sugito K, Furuya T, Kaneda H, Masuko T, et al. Application of high-dose rate Co-60 remote after loading system for local recurrent neuroblastoma. J Pediatr Surg 2011; 46:E25–E28.

Sukumari-Ramesh S, Bentley JN, Laird MD, Singh N, et al. Dietary phytochemicals induce p53-and caspase-independent cell death in human neuroblastoma cells. Int J Dev Neurosci 2011; 29:701–710.

Sulpizio M, Falone S, Amicarelli F, Marchisio M, et al. Molecular Basis Underlying the Biological Effects Elicited by Extremely Low-Frequency Magnetic Field (ELF-MF) on Neuroblastoma Cells. J Cell Biochem 2011; 112:3797–3806.

Tajiri T, Souzaki R, Kinoshita Y, Koga Y, et al. Implications of surgical intervention in the treatment of neuroblastomas: 20-year experience of a single institution. Surg Today 2012; 42:220–224.

Tanaka K, Tamiya-Koizumi K, Hagiwara K, Ito H, et al. Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells. J Biochem 2012; 151:611–620.

Thi VHP, Hartomo TB, Lee MJ, Hasegawa D, et al. Rab15 alternative splicing is altered in spheres of neuroblastoma cells. Oncol Rep 2012; 27:2045–2049.

Timeus F, Crescenzio N, Doria A, Foglia L, et al. In vitro anti-neuroblastoma activity of saquinavir and its association with imatinib. Oncol Rep 2012; 27:734–740.

Tong HX, Lu CW, Wang QS, Ma LY. Combination of IFN gamma and Chemotherapeutic Agents Increase TRAIL Sensitivity of Neuroblastoma Cell Lines. Eur J Pediatr Surg 2011; 21:304–309.

Travelli C, Drago V, Maldi E, Kaludercic N, et al. Reciprocal Potentiation of the Antitumoral Activities of FK866, an Inhibitor of Nicotinamide Phosphoribosyltransferase, and Etoposide or Cisplatin in Neuroblastoma Cells. J Pharmacol Exp Ther 2011; 338:829–840.

Tsai CW, Lin CY, Lin HH, Chen JH. Carnosic Acid, a Rosemary Phenolic Compound, Induces Apoptosis Through Reactive Oxygen Species-Mediated p38 Activation in Human Neuroblastoma IMR-32 Cells. Neurochem Res 2011; 36:2442–2451.

Tsang PS, Cheuk AT, Chen QR, Song YK, et al. Synthetic Lethal Screen Identifies NF-kappa B as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma - art. no. 101. BMC Cancer 2012; 12:21.

Van dewoestyne M, Kumps C, Swerts K, Menten B, et al. Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization. Int J Cancer 2012; 130:1098–1108.

Vella S, Conti M, Tasso R, Cancedda R, et al. Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells. Int J Cancer 2012; 130:1484–1493.

Verissimo CS, Cheng S, Puigvert JC, Qin Y, et al. Combining Doublecortin-Like Kinase Silencing and Vinca Alkaloids Results in a Synergistic Apoptotic Effect in Neuroblastoma Cells. J Pharmacol Exp Ther 2012; 342:119–130.

Verissimo CS, Molenaar JJ, Fitzsimons CP, Vreugdenhil E. Neuroblastoma therapy: what is in the pipeline? Endocr-Relat Cancer 2011; 18:R213–R231.

Villablanca JG, London WB, Naranjo A, McGrady P, et al. Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group. Clin Cancer Res 2011; 17:6858–6866.

Wan L, Nie GJ, Zhang J, Zhao BL. Overexpression of Human Wild-Type Amyloid-beta Protein Precursor Decreases the Iron Content and Increases the Oxidative Stress of Neuroblastoma SH-SY5Y Cells. J Alzheimers Dis 2012; 30:523–530.

Wang CX, Liu ZH, Woo CW, Li ZJ, et al. EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res 2012; 72:315–324.

Watcharasit P, Visitnonthachai D, Suntararuks S, Thiantanawat A, et al. Low arsenite concentrations induce cell proliferation via activation of VEGF signaling in human neuroblastoma SH-SY5Y cells. Environ Toxicol Pharmacol 2012; 33:53–59.

Weintraub M, Waldman E, Koplewitz B, Bloom AI, et al. A sequential treatment algorithm for infants with stage 4 s neuroblastoma and massive hepatomegaly. Pediatr Blood Cancer 2012; 59:182–184.

Westermark UK, Wilhelm M, Frenzel A, Henriksson MA. The MYCN oncogene and differentiation in neuroblastoma. Semin Cancer Biol 2011; 21:256–266.

Wolff JE, Brown RE, Buryanek J, Pfister S, et al. Preliminary experience with personalized and targeted therapy for pediatric brain tumors. Pediatr Blood Cancer 2012; 59:27–33.

Wszelaki N, Melzig MF. Low level of glutathione can intensify the toxic effect of salsolinol in SH-SY5Y neuroblastoma cell line. Neurotoxicology 2012; 33:424–428.

Wylie L, Philpott A. Neuroblastoma progress on many fronts: The neuroblastoma research symposium. Pediatr Blood Cancer 2012; 58:649–651.

Xu H, Cheung IY, Wei XX, Tran H, et al. Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G(1) checkpoint-defective neuroblastoma. Int J Cancer 2011; 129:1953–1962.

Xu LS, Wang XW, Wan JH, Li T, et al. Sonic Hedgehog pathway is essential for neuroblastoma cell proliferation and tumor growth. Mol Cell Biochem 2012; 364:235–241.

Yagyu S, Iehara T, Gotoh T, Miyachi M, et al. Preoperative analysis of 11q loss using circulating tumor-released DNA in serum: A novel diagnostic tool for therapy stratification of neuroblastoma. Cancer Lett 2011; 309:185–189.

Yu D, Jin C, Leja J, Majdalani N, et al. Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors. J Virol 2011; 85:13114–13123.

Yuasa K, Nagame T, Dohi M, Yanagita Y, et al. cGMP-dependent protein kinase I is involved in neurite outgrowth via a Rho effector, rhotekin, in Neuro2A neuroblastoma cells. Biochem Biophys Res Commun 2012; 421:239–244.

Zage PE, Louis CU, Cohn SL. New Aspects of Neuroblastoma Treatment: ASPHO 2011 Symposium Review. Pediatr Blood Cancer 2012; 58:1099–1105.

Zage PE, Nolo R, Fang W, Stewart J, et al. Notch pathway activation induces neuroblastoma tumor cell growth arrest. Pediatr Blood Cancer 2012; 58:682–689.

Zhang Q, Ma Y, Cheng YF, Li WJ, et al. Involvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cells. Cancer Lett 2011; 313:201–210.

Zhi F, Gong GM, Xu Y, Zhu Y, et al. Activated beta-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma. Int J Biol Sci 2012; 8:289–297.

Back to Top | Article Outline

New drug development in pediatric cancer

Bates SE. Progress in Pediatric Cancer. Clin Cancer Res 2012; 18:2734.

Carol H, Boehm I, Reynolds CP, Kang MH, et al. Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer. Cancer Chemother Pharmacol 2011; 68:1291–1304.

Esser R, Muller T, Stefes D, Kloess S, et al. NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin. J Cell Mol Med 2012; 16:569–581.

Kachanov DY. Information about the 7(th) International Workshop ‘‘Biological Bases of Therapy for Cancer and Hematological Diseases’' and 2(nd) Inter-Regional Meeting of the National Society of Pediatric Hematologists and Oncologists. Gematol Transfuziol 2011; 56:37–39.

Lee DW, Barrett DM, Mackall C, Orentas R, et al. The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer. Clin Cancer Res 2012; 18:2780–2790.

Megalizzi V, Le Mercier M, Decaestecker C. Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy. Med Res Rev 2012; 32:410–427.

Pinto N, Cohn SL, Dolan ME. Using Germline Genomics to Individualize Pediatric Cancer Treatments. Clin Cancer Res 2012; 18:2791–2800.

Rossig C, Juergens H, Berdel WE. New Targets and Targeted Drugs for the Treatment of Cancer: An Outlook to Pediatric Oncology. Pediatr Hematol Oncol 2011; 28:539–555.

Thiele CJ, Cohn SL. Genetically InFormed Therapies-A ‘‘GIFT’' for Children with Cancer. Clin Cancer Res 2012; 18: 2735–2739.

Back to Top | Article Outline

Orthopedics

Pediatric upper extremity stress injuries

Review: (pp. 40–45)

Carson JT, McCambridge TM, Carrino JA, McFarland EG. Bilateral Proximal Epiphyseal Clavicular Stress-related Lesions in a Male Gymnast. Clin Orthop Rel Res 2012; 470:307–311.

Franz RW, Skytta CK, Shah KJ, Hartman JF, et al. A Five-Year Review of Management of Upper-Extremity Arterial Injuries at an Urban Level I Trauma Center. Ann Vasc Surg 2012; 26:655–664.

Iyer RS, Thapa MM, Khanna PC, Chew FS. Pediatric Bone Imaging: Imaging Elbow Trauma in Children-A Review of Acute and Chronic Injuries. Am J Roentgenol 2012; 198:1053–1068.

Karnwal A, Liao W, Julka IS, Kakazu CZ. Stellate ganglion block for postoperative analgesia in patients with upper extremity orthopaedic injuries. Anaesthesia 2011; 66:1052–1053.

▪. Kramer DE. Elbow pain and injury in young athletes. J Pediatr Orthop 2010; 30:S7. [10]

▪▪. Mariscalco MW, Saluan P. Upper extremity injuries in the adolescent athlete. Sports Med Arthrosc 2011; 19:17. [04]

Wunschel M, Bohringer A. Osteochondritis Dissecans of Both Knees, Both Elbows, and the First Metatarsophalangeal Joint in a Female Soccer Player. Clin J Sport Med 2012; 22:374–376.

Back to Top | Article Outline

Osteochondritis dissecans of the knee in children and adolescents

Review: (pp. 46–51)

Boughanem J, Riaz R, Patel RM, Sarwark JF. Functional and Radiographic Outcomes of Juvenile Osteochondritis Dissecans of the Knee Treated With Extra-Articular Retrograde Drilling. Am J Sports Med 2011; 39:2212–2217.

Chotel F, Knorr G, Simian E, Dubrana F, et al. Knee osteochondral fractures in skeletally immature patients: French multicenter study. Orthop Traumatol-Surg Res 2011; 97: S154–S159.

▪▪. Edmonds EW, Polousky J. A review of knowledge in osteochondritis dissecans: 123 years of minimal evolution from Konig to the ROCK Study Group. Clin Orthop Relat Res 2012. [Epub ahead of print] [07]

Fabricant PD, Osbahr DC, Green DW. Management of a Rare Complication After Screw Fixation of a Pediatric Tibial Spine Avulsion Fracture: A Case Report With Follow-Up to Skeletal Maturity. J Orthop Trauma 2011; 25:E115–E119.

Hoffmann M, Petersen JP, Schroder M, Hartel M, et al. Accuracy Analysis of a Novel Electromagnetic Navigation Procedure Versus a Standard Fluoroscopic Method for Retrograde Drilling of Osteochondritis Dissecans Lesions of the Knee. Am J Sports Med 2012; 40:920–926.

Hussain WM, Hussain HM, Hussain MS, Ho SSW. Human growth hormone and the development of osteochondritis dissecans lesions. Knee Surg Sports Traumatol Arthrosc 2011; 19:2108–2110.

Iwasaki N, Kamishima T, Kato H, Funakoshi T, et al. A Retrospective Evaluation of Magnetic Resonance Imaging Effectiveness on Capitellar Osteochondritis Dissecans Among Overhead Athletes. Am J Sports Med 2012; 40:624–630.

▪. Kon E, Vannini F, Buda R, et al. How to treat osteochondritis dissecans of the knee: surgical techniques and new trends: AAOS exhibit selection. J Bone Joint Surg Am 2012; 94:e11–e18. [25]

Kon E, Vannini F, Buda R, Filardo G, et al. How to Treat Osteochondritis Dissecans of the Knee: Surgical Techniques and New Trends AAOS Exhibit Selection. J Bone Joint Surg-Am Vol 2012; 94A:85.

▪. Lim HC, Bae JH, Park YE, et al. Long-term results of arthroscopic excision of unstable osteochondral lesions of the lateral femoral condyle. J Bone Joint Surg Br 2012; 94:185–189. [13]

Quatman CE, Quatman-Yates CC, Schmitt LC, Paterno MV. The Clinical Utility and Diagnostic Performance of MRI for Identification and Classification of Knee Osteochondritis Dissecans. J Bone Joint Surg-Am Vol 2012; 94A:1036–1044.

Wunschel M, Bohringer A. Osteochondritis Dissecans of Both Knees, Both Elbows, and the First Metatarsophalangeal Joint in a Female Soccer Player. Clin J Sport Med 2012; 22:374–376.

Back to Top | Article Outline

Femoral fractures in children

Review: (pp. 52–57)

Bengtson H, Giangarra C. Osteochondral Avulsion Fracture of the Anterior Cruciate Ligament Femoral Origin in a 10-Year-Old Child: A Case Report. J Athl Train 2011; 46:451–455.

Ceroni D, Martin X, Delhumeau C, Rizzoli R, et al. Effects of Cast-Mediated Immobilization on Bone Mineral Mass at Various Sites in Adolescents with Lower-Extremity Fracture. J Bone Joint Surg-Am Vol 2012; 94A:208–216.

▪. Dhar SA, Ali MF, Dar TA, et al. Delayed fixation of the transcervical fracture of the neck of the femur in the pediatric population: results and complications. J Child Orthop 2009; 3:473–477. [09]

▪. Heideken J, Svensson T, Blomqvist P, et al. Incidence and trends in femur shaft fractures in Swedish children between 1987 and 2005. J Pediatr Orthop 2011; 31:512–519. [03]

▪. Keeler KA, Dart B, Luhmann SJ, et al. Antegrade intramedullary nailing of pediatric femoral fractures using an interlocking pediatric femoral nail and a lateral trochanteric entry point. J Pediatr Orthop 2009; 29:345–351. [43]

▪. MacNeil JA, Francis A, El-Hawary R. A systematic review of rigid, locked, intramedullary nail insertion sites and avascular necrosis of the femoral head in the skeletally immature. J Pediatr Orthop 2011; 31:377–380. [45]

Mazurek T, Lorczynski A, Ceynowa M. Bilateral femoral neck fracture in a child: a 17-year follow-up. J Pediatr Orthop-Part B 2011; 20:295–298.

▪▪. Reynolds R, Legakis JE, Thomas R, et al. Intramedullary nails for paediatric femur fractures in older, heavier children: early results. J Child Orthop 2012; 6:181–188. [46]

▪. Slongo T, Audige L, Hunter JB, et al. Clinical evaluation of ends caps in elastic stable intramedullary nailing of femoral and tibial shaft fractures in children. Eur J Trauma Emerg Surg 2011; 37:305–372. [28]

▪. Song KS. Displaced fracture of the femoral neck in children: open versus closed reduction. J Bone Joint Surg Br 2010; 92:1148–1151. [11]

Back to Top | Article Outline

Osteomyelitis and septic arthritis in children: current concepts

Review: (pp. 58–63)

▪. Basmaci R, Ilharreborde B, Bidet P, et al. Isolation of Kingella kingae in the oropharynx during K. kingae arthritis in children. Clin Microbiol Infect 2012; 18:E134–E136. [26]

▪. Belthur MV, Birchansky SB, Verdugo AA, et al. Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am 2012; 94:34–42. [42]

▪. Browne LP, Guillerman RP, Orth RC, et al. Community-acquired staphylococcal musculoskeletal infection in infants and young children: necessity of contrast-enhanced MRI for the diagnosis of growth cartilage involvement. Am J Roentgenol 2012; 198:194–199. [20]

▪. Carpenter CR, Schuur JD, Everett WW, Pines JM. Evidence-based diagnostics: adult septic arthritis. Acad Emerg Med 2011; 18:781–796. [28]

▪. Ceroni D, Cherkaoui A, Combescure C, et al. Differentiating osteoarticular infections caused by Kingella kingae from those due to typical pathogens in young children. Pediatr Infect Dis J 2011; 30:906–909. [10]

▪. Dartnell J, Ramachandran M, Katchburian M. Haematogenous acute and subacute paediatric osteomyelitis: a systematic review of the literature. J Bone Joint Surg Br 2012; 94:584–595. [04]

Faust SN, Clark J, Pallett A, Clarke NMP. Managing bone and joint infection in children. Arch Dis Childhood-Educ Pract Ed 2012; 97:545.

▪. Harel L, Prais D, Bar-On E, et al. Dexamethasone therapy for septic arthritis in children: results of a randomized double-blind placebo-controlled study. J Pediatr Orthop 2011; 31:211–215. [36]

Ju KL, Zurakowski D, Kocher MS. Differentiating Between Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Osteomyelitis in Children. J Bone Joint Surg-Am Vol 2011; 93A:1693–1701.

▪. Lehours P, Freydiere AM, Richer O, et al. The rtxA toxin gene of Kingella kingae: a pertinent target for molecular diagnosis of osteoarticular infections. J Clin Microbiol 2011; 49:1245–1250. [27]

▪. Otto M. MRSA virulence and spread. Cell Microbiol 2012; 14:1513–1521. [15]

Paakkonen M, Kallio MJT, Kallio P, Peltola H. Childhood osteomyelitis complicated by adjacent septic arthritis: antibiotic treatment and prognosis. J Pediatr Orthop-Part B 2011; 20:422–427.

Paakkonen M, Peltola H. Management of a child with suspected acute septic arthritis. Arch Dis Child 2012; 97:287–292.

Peltola H, Paakkonen M, Kallio P, Kallio MJT. Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhoodua prospective quasi-randomized controlled trial. Clin Microbiol Infect 2012; 18:582–589.

▪. Robertson AJ, Firth GB, Truda C, et al. Epidemiology of acute osteoarticular sepsis in a setting with a high prevalence of pediatric HIV infection. J Pediatr Orthop 2012; 32:215–219. [16]

Sonnery-Cottet B, Archbold P, Zayni R, Bortolletto J, et al. Prevalence of Septic Arthritis After Anterior Cruciate Ligament Reconstruction Among Professional Athletes. Am J Sports Med 2011; 39:2371–2376.

▪. Sukswai P, Kovitvanitcha D, Thumkunanon V, et al. Acute hematogenous osteomyelitis and septic arthritis in children: clinical characteristics and outcomes study. J Med Assoc Thai 94(Suppl 3)2011:S209–S216. [37]

▪. Warmann SW, Dittmann H, Seitz G, et al. Follow-up of acute osteomyelitis in children: the possible role of PET/CT in selected cases. J Pediatr Surg 2011; 46:1550–1556. [22]

Back to Top | Article Outline

Anterior cruciate ligament prevention strategies: are they effective in young athletes – current concepts and review of literature

Review: (pp. 64–71)

▪. Bien DP. Rationale and implementation of anterior cruciate ligament injury prevention warm-up programs in female athletes. J Strength Cond Res 2011; 25:271–285. [20]

Borbon CA, Mouzopoulos G, Siebold R. Why perform an ACL augmentation? Knee Surg Sports Traumatol Arthrosc 2012; 20:245–251.

Busch MT, Fernandez MD, Aarons C. Partial Tears of the Anterior Cruciate Ligament in Children and Adolescents. Clin Sports Med 2011; 30:743.

Delince P, Ghafil D. Anterior cruciate ligament tears: conservative or surgical treatment? A critical review of the literature. Knee Surg Sports Traumatol Arthrosc 2012; 20:48–61.

Donnelly CJ, Lloyd DG, Elliott BC, Reinbolt JA. Optimizing whole-body kinematics to minimize valgus knee loading during sidestepping: Implications for ACL injury risk. J Biomech 2012; 45:1491–1497.

Dowling AV, Favre J, Andriacchi TP. Inertial Sensor-Based Feedback Can Reduce Key Risk Metrics for Anterior Cruciate Ligament Injury During Jump Landings. Am J Sports Med 2012; 40:1075–1083.

▪▪. Hewett TE, Myer GD, Ford KR, et al. The 2012 ABJS Nicolas Andry Award: the sequence of prevention: a systematic approach to prevent anterior cruciate ligament injury. Clin Orthop Relat Res 2012; 470:2930–2940. [34]

Ioncu A, Mader R, Bonin N, Ternamian PJ, et al. Bone-patellar tendon-bone graft via a single minimally-invasive approach versus a classical approach in anterior cruciate ligament reconstruction: A prospective study. Orthop Traumatol-Surg Res 2012; 98:426–431.

Isberg J, Faxen E, Laxdal G, Eriksson BI, et al. Will early reconstruction prevent abnormal kinematics after ACL injury? Two-year follow-up using dynamic radiostereometry in 14 patients operated with hamstring autografts. Knee Surg Sports Traumatol Arthrosc 2011; 19:1634–1642.

Li B, Bai LH, Fu YH, Wang GB, et al. Effect of Timing of Surgery in Partially Injured ACLs. Orthopedics 2012; 35:408–412.

Li H, Yao ZJ, Jiang J, Hua YH, et al. Biologic Failure of a Ligament Advanced Reinforcement System Artificial Ligament in Anterior Cruciate Ligament Reconstruction: A Report of Serious Knee Synovitis. Arthroscopy 2012; 28:583–586.

Lipps DB, Oh YK, Ashton-Miller JA, Wojtys EM. Morphologic Characteristics Help Explain the Gender Difference in Peak Anterior Cruciate Ligament Strain During a Simulated Pivot Landing. Am J Sports Med 2012; 40:32–40.

▪▪. Marx RG, Myklebust G, Boyle BW. The ACL solution. Prevention and recovery for sport's most devastating knee injury. 1st ed. New York: demosHealth; 2012. [71]

▪. Paterno MV, Rauh MJ, Schmitt LC, et al. Incidence of contralateral and ipsilateral anterior cruciate ligament (ACL) injury after primary ACL reconstruction and return to sport. Clin J Sport Med 2012; 22:116–121. [10]

▪▪. Quatman-Yates CC, Quatman CE, Meszaros AJ, et al. A systematic review of sensorimotor function during adolescence: a developmental stage of increased motor awkwardness? Br J Sports Med 2012; 46:649–655. [67]

▪▪. Sadoghi P, von Keudell A, Vavken P. Effectiveness of anterior cruciate ligament injury prevention training programs. J Bone Joint Surg Am 2012; 94:769–776. [57]

Smith HC, Johnson RJ, Shultz SJ, Tourville T, et al. A Prospective Evaluation of the Landing Error Scoring System (LESS) as a Screening Tool for Anterior Cruciate Ligament Injury Risk. Am J Sports Med 2012; 40:521–526.

Wall SJ, Rose DM, Sutter EG, Belkoff SM, et al. The Role of Axial Compressive and Quadriceps Forces in Noncontact Anterior Cruciate Ligament Injury A Cadaveric Study. Am J Sports Med 2012; 40:568–573.

Back to Top | Article Outline

Cervical spine anomalies in children and adolescents

Review: (pp. 72–77)

Gamie Z, Tran GT, Vyzas G, Korres N, et al. Stem cells combined with bone graft substitutes in skeletal tissue engineering. Expert Opin Biol Ther 2012; 12:713–729.

Ghosh PS, Moodley M, Friedman NR, Rothner AD, et al. Hirayama Disease in Children From North America. J Child Neurol 2011; 26:1542–1547.

▪. Hill SC, Dwyer AJ, Kaler SG. Cervical spine anomalies in Menkes disease: a radiologic finding potentially confused with child abuse. Pediatr Radiol 2012; 42:1301–1304. [09]

Jones TM, Anderson PA, Noonan KJ. Pediatric Cervical Spine Trauma. J Am Acad Orthop Surg 2011; 19:600–611.

▪. Lee CS, Noh H, Lee DH, et al. Analysis of sagittal spinal alignment in 181 asymptomatic children. J Spinal Disord Tech 2012; 25:E259–E263. [07]

Markula-Patjas KP, Valta HL, Kerttula LI, Soini IH, et al. Prevalence of Vertebral Compression Fractures and Associated Factors in Children and Adolescents with Severe Juvenile Idiopathic Arthritis. J Rheumatol 2012; 39:365–373.

Mohseni S, Talving P, Branco BC, Chan LS, et al. Effect of age on cervical spine injury in pediatric population: a National Trauma Data Bank review. J Pediatr Surg 2011; 46:1771–1776.

Rodd C, Lang B, Ramsay T, Alos N, et al. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: A national observational study. Arthritis Care Res 2012; 64:122–131.

Samartzis D, Kalluri P, Herman J, Lubicky JP, et al. Cervical Scoliosis in the Klippel-Feil Patient. Spine 2011; 36:E1501–E1508.

Shen XL, Zhou XH, Chen J, Tian Y, et al. Weakness of the neck extensors, possible causes and relation to adolescent idiopathic cervical kyphosis. Med Hypotheses 2011; 77:456–459.

Wang J, Fu HH, Yang HW, Wang LZ, et al. Clinical management of cervical ectopic thymus in children. J Pediatr Surg 2011; 46:E33–E36.

Yaszay B, O'Brien M, Shufflebarger HL, Betz RR, et al. Efficacy of Hemivertebra Resection for Congenital Scoliosis A Multicenter Retrospective Comparison of Three Surgical Techniques. Spine 2011; 36:2052–2060.

Back to Top | Article Outline

Clinical techniques and outcomes

Adali N, Mars M, Petrie A, Noar J, et al. Presurgical Orthopedics Has No Effect on Archform in Unilateral Cleft Lip and Palate. Cleft Palate-Craniofac J 2012; 49:5–13.

Back DA, Haberstroh N, Hoff E, Plener J, et al. Implementation of the eLearning project NESTOR. A network for students in traumatology and orthopedics. Chirurg 2012; 83:45.

Chotel F, Nguiabanda L, Braillon P, Kohler R, et al. Induced membrane technique for reconstruction after bone tumor resection in children: A preliminary study. Orthop Traumatol-Surg Res 2012; 98:301–308.

Dawe E, Reeve W, Burkes M. Tips for GP trainees working in trauma and orthopaedics. Br J Gen Pract 2011; 61:532–533.

Dorsi MJ, Belzberg AJ. Nerve transfers for restoration of upper extremity motor function in a child with upper extremity motor deficits due to transverse myelitis: Case report. Microsurgery 2012; 32:64–67.

Ducic I, Felder JM, Quadri HS. Common Nerve Decompressions of the Upper Extremity Reliable Exposure Using Shorter Incisions. Ann Plast Surg 2012; 68:606–609.

Funk JF, Seidl T, Perka C, Haas NP, et al. Locking Plates for Osteosyntheses of Corrective Osteotomies in Paediatric Orthopaedic and Neuroorthopaedic Patients. Z Orthop Unfallchir 2011; 149:428–435.

Halvorson J, Jinnah R, Kulp B, Frino J. Use of Vacuum-assisted Closure in Pediatric Open Fractures With a Focus on the Rate of Infection. Orthopedics 2011; 34:E256–E260.

Hoffmann M, Petersen JP, Schroder M, Hartel M, et al. Accuracy Analysis of a Novel Electromagnetic Navigation Procedure Versus a Standard Fluoroscopic Method for Retrograde Drilling of Osteochondritis Dissecans Lesions of the Knee. Am J Sports Med 2012; 40:920–926.

Hui JHP, Chowdhary A. Reconstruction of Anterior Cruciate Ligament in Children: Hamstring versus Bone Patella Tendon Bone Graft. Clin Sports Med 2011; 30:751.

Isberg J, Faxen E, Laxdal G, Eriksson BI, et al. Will early reconstruction prevent abnormal kinematics after ACL injury? Two-year follow-up using dynamic radiostereometry in 14 patients operated with hamstring autografts. Knee Surg Sports Traumatol Arthrosc 2011; 19:1634–1642.

Iyer RS, Thapa MM, Khanna PC, Chew FS. Pediatric Bone Imaging: Imaging Elbow Trauma in Children-A Review of Acute and Chronic Injuries. Am J Roentgenol 2012; 198:1053–1068.

Jay GD, Elsaid KA, Kelly KA, Anderson SC, et al. Prevention of Cartilage Degeneration and Gait Asymmetry by Lubricin Tribosupplementation in the Rat Following Anterior Cruciate Ligament Transection. Arthritis Rheum 2012; 64:1162–1171.

Klugman MF, Brent JL, Myer GD, Ford KR, et al. Does an In-Season Only Neuromuscular Training Protocol Reduce Deficits Quantified by the Tuck Jump Assessment? Clin Sports Med 2011; 30:825.

Kraus T, Heidari N, Svehlik M, Schneider F, et al. Outcome of repaired unstable meniscal tears in children and adolescents. Acta Orthop 2012; 83:261–266.

Lascombes P, Nespola A, Poircuitte JM, Popkov D, et al. Early complications with flexible intramedullary nailing in childhood fracture: 100 cases managed with precurved tip and shaft nails. Orthop Traumatol-Surg Res 2012; 98:369–375.

Lazar-Antman MA, Leet AI. Effects of Obesity on Pediatric Fracture Care and Management. J Bone Joint Surg-Am Vol 2012; 94A:855–861.

Li B, Bai LH, Fu YH, Wang GB, et al. Effect of Timing of Surgery in Partially Injured ACLs. Orthopedics 2012; 35:408–412.

Li H, Yao ZJ, Jiang J, Hua YH, et al. Biologic Failure of a Ligament Advanced Reinforcement System Artificial Ligament in Anterior Cruciate Ligament Reconstruction: A Report of Serious Knee Synovitis. Arthroscopy 2012; 28:583–586.

Lubowitz JH, Provencher MT, Poehling GG. Do Large-Diameter Hamstring Grafts in Young Patients Prevent Knee Osteoarthritis After ACL Reconstruction? Arthroscopy 2012; 28:447–448.

Marino RJ, Patrick M, Albright W, Leiby BE, et al. Development of an Objective Test of Upper-Limb Function in Tetraplegia The Capabilities of Upper Extremity Test. Am J Phys Med Rehabil 2012; 91:478–486.

Milewski MD, Beck NA, Lawrence JT, Ganley TJ. Anterior Cruciate Ligament Reconstruction in the Young Athlete: A Treatment Algorithm for the Skeletally Immature. Clin Sports Med 2011; 30:801.

Page MG, Campbell F, Isaac L, Stinson J, et al. Reliability and validity of the Child Pain Anxiety Symptoms Scale (CPASS) in a clinical sample of children and adolescents with acute postsurgical pain. Pain 2011; 152:1958–1965.

Pan RY, Yang JJ, Chang JH, Shen HC, et al. Clinical outcome of arthroscopic fixation of anterior tibial eminence avulsion fractures in skeletally mature patients: A comparison of suture and screw fixation technique. J Trauma Acute Care Surg 2012; 72:E88–E93.

Petersen W. Does ACL Reconstruction Lead to Degenerative Joint Disease or Does It Prevent Osteoarthritis? How to Read Science. Arthroscopy 2012; 28:448–450.

Quatman CE, Quatman-Yates CC, Schmitt LC, Paterno MV. The Clinical Utility and Diagnostic Performance of MRI for Identification and Classification of Knee Osteochondritis Dissecans. J Bone Joint Surg-Am Vol 2012; 94A:1036–1044.

Ross PA, Smith BM, Tolo VT, Khemani RG. Continuous Infusion of Bupivacaine Reduces Postoperative Morphine Use in Adolescent Idiopathic Scoliosis After Posterior Spine Fusion. Spine 2011; 36:1478–1483.

Shetye PR. Presurgical Infant Orthopedics. J Craniofac Surg 2012; 23:210–211.

Taub E, Griffin A, Uswatte G, Gammons K, et al. Treatment of Congenital Hemiparesis With Pediatric Constraint-Induced Movement Therapy. J Child Neurol 2011; 26: 1163–1173.

Tomita Y, Kuroda S, Katsura T, Watanabe T, et al. Severity of alveolar cleft before palatoplasty affects vertical maxillofacial growth in 6-year-old patients with complete unilateral cleft lip and palate. Am J Orthod Dentofac Orthop 2012; 141:S102–S109.

Walz B, Nyland J, Fisher B, Krupp R, et al. Supplemental bio-tenodesis improves tibialis anterior allograft yield load in extremely low density tibiae. Arch Orthop Trauma Surg 2012; 132:343–347.

Wang Y, Liu H. Obstacle and solution of Chinese evidence-based orthopedics. Chin Med J 2011; 124:3848–3849.

Back to Top | Article Outline

Musculoskeletal pain, trauma and abnormalities

Abrams GD, Renstrom PA, Safran MR. Epidemiology of musculoskeletal injury in the tennis player. Br J Sports Med 2012; 46:492–498.

Bengtson H, Giangarra C. Osteochondral Avulsion Fracture of the Anterior Cruciate Ligament Femoral Origin in a 10-Year-Old Child: A Case Report. J Athl Train 2011; 46:451–455.

Busch MT, Fernandez MD, Aarons C. Partial Tears of the Anterior Cruciate Ligament in Children and Adolescents. Clin Sports Med 2011; 30:743.

Chotel F, Knorr G, Simian E, Dubrana F, et al. Knee osteochondral fractures in skeletally immature patients: French multicenter study. Orthop Traumatol-Surg Res 2011; 97: S154–S159.

de Putter CE, van Beeck EF, Looman CWN, Toet H, et al. Trends in Wrist Fractures in Children and Adolescents, 1997-2009. J Hand Surg-Am Vol 2011; 36A:1810–1815.

de Visser HM, Reijman M, Heijboer MP, Bos PK. Risk factors of recurrent hamstring injuries: a systematic review. Br J Sports Med 2012; 46:124–130.

Dong L, Donaldson A, Metzger R, Keenan H. Analgesic Administration in the Emergency Department for Children Requiring Hospitalization for Long-Bone Fracture. Pediatr Emerg Care 2012; 28:109–114.

Gokeler A, Benjaminse A, Hewett TE, Lephart SM, et al. Proprioceptive deficits after ACL injury: are they clinically relevant? Br J Sports Med 2012; 46:180–192.

Gottschalk HP, Eisner E, Hosalkar HS. Medial Epicondyle Fractures in the Pediatric Population. J Am Acad Orthop Surg 2012; 20:223–232.

Jay GD, Elsaid KA, Kelly KA, Anderson SC, et al. Prevention of Cartilage Degeneration and Gait Asymmetry by Lubricin Tribosupplementation in the Rat Following Anterior Cruciate Ligament Transection. Arthritis Rheum 2012; 64:1162–1171.

Kraus T, Heidari N, Svehlik M, Schneider F, et al. Outcome of repaired unstable meniscal tears in children and adolescents. Acta Orthop 2012; 83:261–266.

Kraus T, Svehlik M, Singer G, Schalamon J, et al. The epidemiology of knee injuries in children and adolescents. Arch Orthop Trauma Surg 2012; 132:773–779.

Kutilek S, Plasilova I, Nemec V. Once-monthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass. J Paediatr Child Health 2012; 48:622–623.

Lascombes P, Nespola A, Poircuitte JM, Popkov D, et al. Early complications with flexible intramedullary nailing in childhood fracture: 100 cases managed with precurved tip and shaft nails. Orthop Traumatol-Surg Res 2012; 98:369–375.

Lazar-Antman MA, Leet AI. Effects of Obesity on Pediatric Fracture Care and Management. J Bone Joint Surg-Am Vol 2012; 94A:855–861.

Li RT, Lorenz S, Xu Y, Harner CD, et al. Predictors of Radiographic Knee Osteoarthritis After Anterior Cruciate Ligament Reconstruction. Am J Sports Med 2011; 39:2595–2603.

Liporace FA, Yoon RS, Kubiak EN, Parisi DM, et al. Does Adding Computed Tomography Change the Diagnosis and Treatment of Tillaux and Triplane Pediatric Ankle Fractures? Orthopedics 2012; 35:E208–E212.

Lubowitz JH, Provencher MT, Poehling GG. Do Large-Diameter Hamstring Grafts in Young Patients Prevent Knee Osteoarthritis After ACL Reconstruction? Arthroscopy 2012; 28:447–448.

Markula-Patjas KP, Valta HL, Kerttula LI, Soini IH, et al. Prevalence of Vertebral Compression Fractures and Associated Factors in Children and Adolescents with Severe Juvenile Idiopathic Arthritis. J Rheumatol 2012; 39:365–373.

Martinez-Soto T, Pacaud D, Stephure D, Trussell R, et al. Treatment of symptomatic osteoporosis in children: a comparison of two pamidronate dosage regimens. J Pediatr Endocrinol Metab 2011; 24:271–274.

Page MG, Campbell F, Isaac L, Stinson J, et al. Reliability and validity of the Child Pain Anxiety Symptoms Scale (CPASS) in a clinical sample of children and adolescents with acute postsurgical pain. Pain 2011; 152:1958–1965.

Paloski M, Taylor BC, Iobst C, Pugh KJ. Pediatric and Adolescent Applications of the Taylor Spatial Frame. Orthopedics 2012; 35:518–527.

Pan RY, Yang JJ, Chang JH, Shen HC, et al. Clinical outcome of arthroscopic fixation of anterior tibial eminence avulsion fractures in skeletally mature patients: A comparison of suture and screw fixation technique. J Trauma Acute Care Surg 2012; 72:E88–E93.

Petersen W. Does ACL Reconstruction Lead to Degenerative Joint Disease or Does It Prevent Osteoarthritis? How to Read Science. Arthroscopy 2012; 28:448–450.

Pitts SAB, Feldman HA, Dorale A, Gordon CM. Bone Mineral Density, Fracture, and Vitamin D in Adolescents and Young Women Using Depot Medroxyprogesterone Acetate. J Pediatr Adolesc Gynecol 2012; 25:23–26.

Pourtaheri N, Strongwater AM. Clavicle Nonunion in a 10-year-old Boy. Orthopedics 2012; 35:E442–E443.

Quemeneur AS, Trocello JM, Ea HK, Woimant F, et al. Musculoskeletal conditions associated with Wilson's disease. Best Pract Res Clin Rheumatol 2011; 25:627–636.

Rianthavorn P, Pisutikul K, Deekajorndech T, Tepmongkol S, et al. Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone. J Pediatr Endocrinol Metab 2012; 25:307–312.

Schalamon J, Dampf S, Singer G, Ainoedhofer H, et al. Evaluation of Fractures in Children and Adolescents in a Level I Trauma Center in Austria. J Trauma-Injury Infect Crit Care 2011; 71:E19–E25.

Schulte TL, Trost M, Osada N, Huck K, et al. Publication rate of abstracts presented at the Annual Congress of the German Society of Orthopaedics and Trauma Surgery. Arch Orthop Trauma Surg 2012; 132:271–280.

Sheehan FT, Sipprell WH, Boden BP. Dynamic Sagittal Plane Trunk Control During Anterior Cruciate Ligament Injury. Am J Sports Med 2012; 40:1068–1074.

Siberry GK, Li H, Jacobson D. Short Communication: Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children. Aids Res Hum Retrovir 2012; 28:247–250.

Sonnery-Cottet B, Archbold P, Zayni R, Bortolletto J, et al. Prevalence of Septic Arthritis After Anterior Cruciate Ligament Reconstruction Among Professional Athletes. Am J Sports Med 2011; 39:2371–2376.

Sonneville KR, Gordon CM, Kocher MS, Pierce LM, et al. Vitamin D, Calcium, and Dairy Intakes and Stress Fractures Among Female Adolescents. Arch Pediatr Adolesc Med 2012; 166:595–600.

Stevens MW, Hainsworth KR, Weisman SJ, Layde PM. Health-Related Quality of Life in Pediatric Minor Injury Reliability, Validity, and Responsiveness of the Pediatric Quality of Life Inventory in the Emergency Department. Arch Pediatr Adolesc Med 2012; 166:74–81.

Tamminen IS, Mayranpaa MK, Turunen MJ, Isaksson H, et al. Altered Bone Composition in Children With Vertebral Fracture. J Bone Miner Res 2011; 26:2226–2234.

Thapa MM, Chaturvedi A, Darling SE, Khanna PC, et al. MRI of Pediatric Patients: Part 2, Normal Variants and Abnormalities of the Knee. Am J Roentgenol 2012; 198:W456–W465.

Toplak N, Subelj V, Kveder T, Cucnik S, et al. Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2012; 30:436–444.

Back to Top | Article Outline

Infection

Arpadi SM, McMahon DJ, Abrams EJ, Bamji M, et al. Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial. Am J Clin Nutr 2012; 95:678–685.

Butler EE, Rose J. The Pediatric Upper Limb Motion Index and a temporal-spatial logistic regression: Quantitative analysis of upper limb movement disorders during the Reach & Grasp Cycle. J Biomech 2012; 45:945–951.

Clarke NMP, Page JE. Vitamin D deficiency: a paediatric orthopaedic perspective. Curr Opin Pediatr 2012; 24:46–49.

Dalton EC, Pfile KR, Weniger GR, Ingersoll CD, et al. Neuromuscular Changes After Aerobic Exercise in People with Anterior Cruciate Ligament-Reconstructed Knees. J Athl Train 2011; 46:476–483.

Faust SN, Clark J, Pallett A, Clarke NMP. Managing bone and joint infection in children. Arch Dis Childhood-Educ Pract Ed 2012; 97:545.

Halvorson J, Jinnah R, Kulp B, Frino J. Use of Vacuum-assisted Closure in Pediatric Open Fractures With a Focus on the Rate of Infection. Orthopedics 2011; 34:E256–E260.

Hoffmann C, Pierrot S, Contencin P, Morisseau-Durand MP, et al. Retropharyngeal infections in children. Treatment strategies and outcomes. Int J Pediatr Otorhinolaryngol 2011; 75:1099–1103.

La Riviere CA, Waldhausen JHT. Congenital Cervical Cysts, Sinuses, and Fistulae in Pediatric Surgery. Surg Clin-North Am 2012; 92:583.

Mitha A, Boulyana M, Hue V, Pruvost I, et al. Consensus in diagnostic definitions for bone or joint infections in children by a Delphi method with European French-speaking experts. Acta Paediatr 2012; 101:e350–e356.

Siberry GK, Li H, Jacobson D. Short Communication: Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children. Aids Res Hum Retrovir 2012; 28:247–250.

Yagerman SE, Cross MB, Green DW, Scher DM. Pediatric orthopedic conditions in Charcot-Marie-Tooth disease: a literature review. Curr Opin Pediatr 2012; 24:50–56.

Back to Top | Article Outline

Bone physiology

Arpadi SM, McMahon DJ, Abrams EJ, Bamji M, et al. Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial. Am J Clin Nutr 2012; 95:678–685.

Bruckner AL, Bedocs LA, Keiser E, Tang JY, et al. Correlates of low bone mass in children with generalized forms of epidermolysis bullosa. J Am Acad Dermatol 2011; 65:1001–1009.

Ceroni D, Martin X, Delhumeau C, Rizzoli R, et al. Effects of Cast-Mediated Immobilization on Bone Mineral Mass at Various Sites in Adolescents with Lower-Extremity Fracture. J Bone Joint Surg-Am Vol 2012; 94A:208–216.

Chen CL, Lin KC, Wu CY, Ke JY, et al. Relationships of muscle strength and bone mineral density in ambulatory children with cerebral palsy. Osteoporosis Int 2012; 23:715–721.

Chobot AP, Haffke A, Polanska J, Halaba ZP, et al. Quantitative ultrasound bone measurements in pre-pubertal children with type 1 diabetes. Ultrasound Med Biol 2012; 38:1109–1115.

Claudet I, Marechal C, Gurrera E, Cordier L, et al. Risk Factors for High-Grade Envenomations After French Viper Bites in Children. Pediatr Emerg Care 2012; 28:650–654.

Cohen LE, Gordon JH, Popovsky EY, Sainath NN, et al. Bone density in post-pubertal adolescent survivors of childhood brain tumors. Pediatr Blood Cancer 2012; 58:959–963.

Dorn LD, Pabst S, Sontag LM, Kalkwarf HJ, et al. Bone Mass, Depressive, and Anxiety Symptoms in Adolescent Girls: Variation by Smoking and Alcohol Use. J Adolesc Health 2011; 49:498–504.

Edouard T, Glorieux FH, Rauch F. Predictors and Correlates of Vitamin D Status in Children and Adolescents with Osteogenesis Imperfecta. J Clin Endocrinol Metab 2011; 96:3193–3198.

Edouard T, Glorieux FH, Rauch F. Relationship Between Vitamin D Status and Bone Mineralization, Mass, and Metabolism in Children With Osteogenesis Imperfecta: Histomorphometric Study. J Bone Miner Res 2011; 26:2245–2251.

Eicher-Miller HA, Mason AC, Weaver CM, McCabe GP, et al. Food Insecurity Is Associated with Diet and Bone Mass Disparities in Early Adolescent Males but Not Females in the United States. J Nutr 2011; 141:1738–1745.

Feng J, Wu Q, Zhang D, Chen BY. Hippocampal impairments are associated with intermittent hypoxia of obstructive sleep apnea. Chin Med J 2012; 125:696–701.

Fu T, Lingala B, Kent K, Bachrach LK, et al. Patterns of bone mineral acquisition in children with epidermolysis bullosa: a longitudinal study. Br J Dermatol 2011; 165:1081–1086.

Funk JF, Seidl T, Perka C, Haas NP, et al. Locking Plates for Osteosyntheses of Corrective Osteotomies in Paediatric Orthopaedic and Neuroorthopaedic Patients. Z Orthop Unfallchir 2011; 149:428–435.

Garcia ST, Sanchez MAG, Cejudo P, Gallego EQ, et al. Bone Health, Daily Physical Activity, and Exercise Tolerance in Patients With Cystic Fibrosis. Chest 2011; 140:475–481.

Gong J, Xu Y, Guo B, Xu H. DXA Femoral Neck Strength Analysis in Chinese Overweight and Normal Weight Adolescents. J Clin Densitom 2012; 15:146–151.

Gracia-Marco L, Ortega FB, Casajus JA, Sioen I, et al. Socioeconomic Status and Bone Mass in Spanish Adolescents. The HELENA Study. J Adolesc Health 2012; 50:484–490.

Gracia-Marco L, Ortega FB, Jimenez-Pavon D, Rodriguez G, et al. Adiposity and bone health in Spanish adolescents. The HELENA study. Osteoporosis Int 2012; 23:937–947.

Guida G, Iolascon G, Gimigliano F, Gimigliano R. Development of knowledge about osteoporosis in the world of orthopedics and traumatology. Aging Clin Exp Res 2011; 23:8–9.

Hamed EA, Abu Faddan NH, Elhafeez HAA, Sayed D. Parathormone-25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2011; 12:536–546.

Harvey NC, Cole ZA, Crozier SR, Kim M, et al. Physical activity, calcium intake and childhood bone mineral: a population-based cross-sectional study. Osteoporosis Int 2012; 23:121–130.

Ionova-Martin SS, Wade JM, Tang S, Shahnazari M, et al. Changes in cortical bone response to high-fat diet from adolescence to adulthood in mice. Osteoporosis Int 2011; 22:2283–2293.

Kutilek S, Plasilova I, Nemec V. Once-monthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass. J Paediatr Child Health 2012; 48:622–623.

Li M, Xia WB, Xing XP, Yu W, et al. Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta. Chin Med J 2011; 124:3049–3053.

Maggio ABR, Rizzoli RR, Marchand LM, Ferrari S, et al. Physical Activity Increases Bone Mineral Density in Children with Type 1 Diabetes. Med Sci Sports Exerc 2012; 44:1206–1211.

Martinez-Soto T, Pacaud D, Stephure D, Trussell R, et al. Treatment of symptomatic osteoporosis in children: a comparison of two pamidronate dosage regimens. J Pediatr Endocrinol Metab 2011; 24:271–274.

Mayranpaa MK, Viljakainen HT, Toiviainen-Salo S, Kallio PE, et al. Impaired bone health and asymptomatic vertebral compressions in fracture-prone children: A case-control study. J Bone Miner Res 2012; 27:1413–1424.

Modlesky CM, Bajaj D, Kirby JT, Mulrooney BM, et al. Sex differences in trabecular bone microarchitecture are not detected in pre and early pubertal children using magnetic resonance imaging. Bone 2011; 49:1067–1072.

Pirinccioglu AG, Akpolat V, Koksal O, Haspolat K, et al. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone 2011; 49:819–823.

Pitts SAB, Feldman HA, Dorale A, Gordon CM. Bone Mineral Density, Fracture, and Vitamin D in Adolescents and Young Women Using Depot Medroxyprogesterone Acetate. J Pediatr Adolesc Gynecol 2012; 25:23–26.

Rayar MS, Nayiager T, Webber CE, Barr RD, et al. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2012; 59:77–82.

Rianthavorn P, Pisutikul K, Deekajorndech T, Tepmongkol S, et al. Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone. J Pediatr Endocrinol Metab 2012; 25:307–312.

Rose SR, Rutter MM, Mueller R, Harris M, et al. Bone Mineral Density Is Normal in Children With Fanconi Anemia. Pediatr Blood Cancer 2011; 57:1034–1038.

Sabharwal S, MacLeod R. Ilizarov hip reconstruction for the management of advanced osteonecrosis in an adolescent with leukemia. J Pediatr Orthop-Part B 2012; 21:252–259.

Sayers A, Lawlor DA, Sattar N, Tobias JH. The association between insulin levels and cortical bone: Findings from a cross-sectional analysis of pQCT parameters in adolescents. J Bone Miner Res 2012; 27:610–618.

Shepherd JA, Wang L, Fan B, Gilsanz V, et al. Optimal Monitoring Time Interval Between DXA Measures in Children. J Bone Miner Res 2011; 26:2745–2752.

Simm PJ, Johannesen J, Briody J, McQuade M, et al. Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis. Bone 2011; 49:939–943.

Tamminen IS, Mayranpaa MK, Turunen MJ, Isaksson H, et al. Altered Bone Composition in Children With Vertebral Fracture. J Bone Miner Res 2011; 26:2226–2234.

Tubbs RS, Muhleman M, Miller J, Shoja MM, et al. Cervical ribs with neurological sequelae in children: a case series. Childs Nerv Syst 2012; 28:605–608.

Valteau B, Grimard G, Londono I, Moldovan F, et al. In vivo dynamic bone growth modulation is less detrimental but as effective as static growth modulation. Bone 2011; 49:996–1004.

Zbojniewicz AM, Laor T. Focal Periphyseal Edema (FOPE) Zone on MRI of the Adolescent Knee: A Potentially Painful Manifestation of Physiologic Physeal Fusion? Am J Roentgenol 2011; 197:998–1004.

Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, et al. Revised Reference Curves for Bone Mineral Content and Areal Bone Mineral Density According to Age and Sex for Black and Non-Black Children: Results of the Bone Mineral Density in Childhood Study. J Clin Endocrinol Metab 2011; 96:3160–3169.

Back to Top | Article Outline

Cancer in pediatrics

Albertini AF, Brousse N, Bodemer C, Calonje E, et al. Retiform Hemangioendothelioma Developed on the Site of an Earlier Cystic Lymphangioma in a Six-Year-Old Girl. Am J Dermatopathol 2011; 33:E84–E87.

Chotel F, Nguiabanda L, Braillon P, Kohler R, et al. Induced membrane technique for reconstruction after bone tumor resection in children: A preliminary study. Orthop Traumatol-Surg Res 2012; 98:301–308.

Hung M, Clegg DO, Greene T, Weir C, et al. A Lower Extremity Physical Function Computerized Adaptive Testing Instrument for Orthopaedic Patients. Foot Ankle Int 2012; 33:326–335.

Jo VY, Marino-Enriquez A, Fletcher CDM. Epithelioid Rhabdomyosarcoma: Clinicopathologic Analysis of 16 Cases of a Morphologically Distinct Variant of Rhabdomyosarcoma. Am J Surg Pathol 2011; 35:1523–1530.

Kaiser MM, Zachert G, Wendlandt R, Rapp M, et al. Biomechanical analysis of a synthetic femoral spiral fracture model: Do end caps improve retrograde flexible intramedullary nail fixation? - art. no. 46. J Orthop Surg Res 2011; 6:18.

Lohiya R, Bachhal V, Khan U, Kumar D, et al. Flexible intramedullary nailing in paediatric femoral fractures. A report of 73 cases - art. no. 64. J Orthop Surg Res 2011; 6:22.

Sabharwal S, MacLeod R. Ilizarov hip reconstruction for the management of advanced osteonecrosis in an adolescent with leukemia. J Pediatr Orthop-Part B 2012; 21:252–259.

Smith AB, Soderlund KA, Rushing EJ, Smirniotopolous JG. Radiologic-Pathologic Correlation of Pediatric and Adolescent Spinal Neoplasms: Part 1, Intramedullary Spinal Neoplasms. Am J Roentgenol 2012; 198:34–43.

Soderlund KA, Smith AB, Rushing EJ, Smirniotopolous JG. Radiologic-Pathologic Correlation of Pediatric and Adolescent Spinal Neoplasms: Part 2, Intradural Extramedullary Spinal Neoplasms. Am J Roentgenol 2012; 198:44–51.

Back to Top | Article Outline

Neurophysiology and disease

Busscher I, Kingma I, de Bruin R, Wapstra FH, et al. Predicting the peak growth velocity in the individual child: validation of a new growth model. Eur Spine J 2012; 21:71–76.

Butler EE, Rose J. The Pediatric Upper Limb Motion Index and a temporal-spatial logistic regression: Quantitative analysis of upper limb movement disorders during the Reach & Grasp Cycle. J Biomech 2012; 45:945–951.

Dalton EC, Pfile KR, Weniger GR, Ingersoll CD, et al. Neuromuscular Changes After Aerobic Exercise in People with Anterior Cruciate Ligament-Reconstructed Knees. J Athl Train 2011; 46:476–483.

Dorsi MJ, Belzberg AJ. Nerve transfers for restoration of upper extremity motor function in a child with upper extremity motor deficits due to transverse myelitis: Case report. Microsurgery 2012; 32:64–67.

Feng J, Wu Q, Zhang D, Chen BY. Hippocampal impairments are associated with intermittent hypoxia of obstructive sleep apnea. Chin Med J 2012; 125:696–701.

Gokeler A, Benjaminse A, Hewett TE, Lephart SM, et al. Proprioceptive deficits after ACL injury: are they clinically relevant? Br J Sports Med 2012; 46:180–192.

Hoffmann C, Pierrot S, Contencin P, Morisseau-Durand MP, et al. Retropharyngeal infections in children. Treatment strategies and outcomes. Int J Pediatr Otorhinolaryngol 2011; 75:1099–1103.

Park KC, Oh CW, Byun YS, Oh JK, et al. Intramedullary nailing versus submuscular plating in adolescent femoral fracture. Injury-Int J Care Inj 2012; 43:870–875.

Philip BA, Frey SH. Preserved grip selection planning in chronic unilateral upper extremity amputees. Exp. Brain Res 2011; 214:437–452.

Sinikumpu JJ, Lautamo A, Pokka T, Serlo W. The increasing incidence of paediatric diaphyseal both-bone forearm fractures and their internal fixation during the last decade. Injury-Int J Care Inj 2012; 43:362–366.

Smith AB, Soderlund KA, Rushing EJ, Smirniotopolous JG. Radiologic-Pathologic Correlation of Pediatric and Adolescent Spinal Neoplasms: Part 1, Intramedullary Spinal Neoplasms. Am J Roentgenol 2012; 198:34–43.

Soderlund KA, Smith AB, Rushing EJ, Smirniotopolous JG. Radiologic-Pathologic Correlation of Pediatric and Adolescent Spinal Neoplasms: Part 2, Intradural Extramedullary Spinal Neoplasms. Am J Roentgenol 2012; 198:44–51.

Tubbs RS, Muhleman M, Miller J, Shoja MM, et al. Cervical ribs with neurological sequelae in children: a case series. Childs Nerv Syst 2012; 28:605–608.

Villardo RJM, Rosas-Salazard C, Spahr JE, Dohar JE. An unusual solitary endobronchial pulmonary arteriovenous malformation in a 10 year-old child. Int J Pediatr Otorhinolaryngol 2011; 75:1463–1467.

Back to Top | Article Outline

Genetic abnormalities

Fu T, Lingala B, Kent K, Bachrach LK, et al. Patterns of bone mineral acquisition in children with epidermolysis bullosa: a longitudinal study. Br J Dermatol 2011; 165:1081–1086.

Quemeneur AS, Trocello JM, Ea HK, Woimant F, et al. Musculoskeletal conditions associated with Wilson's disease. Best Pract Res Clin Rheumatol 2011; 25:627–636.

Yoneda Y, Haginoya K, Arai H, Yamaoka S, et al. De Novo and Inherited Mutations in COL4A2, Encoding the Type IV Collagen alpha 2 Chain Cause Porencephaly. Am J Hum Genet 2012; 90:86–90.

Back to Top | Article Outline

Imaging techniques

Barker SL, Downing M, Chesney DJ, Maffulli N. Assessment of calf volume in congenital talipes equinovarus by computer analysed digital photography. Surg J R Coll Surg Edinb Irel 2012; 10:84–89.

Boughanem J, Riaz R, Patel RM, Sarwark JF. Functional and Radiographic Outcomes of Juvenile Osteochondritis Dissecans of the Knee Treated With Extra-Articular Retrograde Drilling. Am J Sports Med 2011; 39:2212–2217.

Chobot AP, Haffke A, Polanska J, Halaba ZP, et al. Quantitative ultrasound bone measurements in pre-pubertal children with type 1 diabetes. Ultrasound Med Biol 2012; 38:1109–1115.

Gilbert C, Babyn P. MR Imaging of the Neonatal Musculoskeletal System. Magn Reson Imaging Clin N Am 2011; 19:841.

Iwasaki N, Kamishima T, Kato H, Funakoshi T, et al. A Retrospective Evaluation of Magnetic Resonance Imaging Effectiveness on Capitellar Osteochondritis Dissecans Among Overhead Athletes. Am J Sports Med 2012; 40:624–630.

Liporace FA, Yoon RS, Kubiak EN, Parisi DM, et al. Does Adding Computed Tomography Change the Diagnosis and Treatment of Tillaux and Triplane Pediatric Ankle Fractures? Orthopedics 2012; 35:E208–E212.

Modlesky CM, Bajaj D, Kirby JT, Mulrooney BM, et al. Sex differences in trabecular bone microarchitecture are not detected in pre and early pubertal children using magnetic resonance imaging. Bone 2011; 49:1067–1072.

Mussa A, Porta F, Baldassarre G, Tuli G, et al. Phalangeal quantitative ultrasound in 1,719 children and adolescents with bone disorders. Osteoporosis Int 2012; 23:1987–1998.

Piatt JH, Grissom LE. Developmental anatomy of the atlas and axis in childhood by computed tomography. J Neurosurg-Pediatr 2011; 8:235–243.

Thapa MM, Chaturvedi A, Darling SE, Khanna PC, et al. MRI of Pediatric Patients: Part 2, Normal Variants and Abnormalities of the Knee. Am J Roentgenol 2012; 198:W456–W465.

Zbojniewicz AM, Laor T. Focal Periphyseal Edema (FOPE) Zone on MRI of the Adolescent Knee: A Potentially Painful Manifestation of Physiologic Physeal Fusion? Am J Roentgenol 2011; 197:998–1004.

Back to Top | Article Outline

Biomechanics and kinematics

Abdelmoula A, Martin V, Bouchant A, Walrand S, et al. Knee extension strength in obese and nonobese male adolescents. Appl Physiol Nutr Metab 2012; 37:269–275.

Butler EE, Rose J. The Pediatric Upper Limb Motion Index and a temporal-spatial logistic regression: Quantitative analysis of upper limb movement disorders during the Reach & Grasp Cycle. J Biomech 2012; 45:945–951.

Kawamura A, Klejman S, Fehlings D. Reliability and Validity of the Kinematic Dystonia Measure for Children With Upper Extremity Dystonia. J Child Neurol 2012; 27:907–913.

Lipps DB, Oh YK, Ashton-Miller JA, Wojtys EM. Morphologic Characteristics Help Explain the Gender Difference in Peak Anterior Cruciate Ligament Strain During a Simulated Pivot Landing. Am J Sports Med 2012; 40:32–40.

Sharma A, Tallchief D, Blood J, Kim T, et al. Perioperative Pharmacokinetics of Methadone in Adolescents. Anesthesiology 2011; 115:1153–1161.

Sheehan FT, Sipprell WH, Boden BP. Dynamic Sagittal Plane Trunk Control During Anterior Cruciate Ligament Injury. Am J Sports Med 2012; 40:1068–1074.

Smith HC, Johnson RJ, Shultz SJ, Tourville T, et al. A Prospective Evaluation of the Landing Error Scoring System (LESS) as a Screening Tool for Anterior Cruciate Ligament Injury Risk. Am J Sports Med 2012; 40:521–526.

Wall SJ, Rose DM, Sutter EG, Belkoff SM, et al. The Role of Axial Compressive and Quadriceps Forces in Noncontact Anterior Cruciate Ligament Injury A Cadaveric Study. Am J Sports Med 2012; 40:568–573.

Walz B, Nyland J, Fisher B, Krupp R, et al. Supplemental bio-tenodesis improves tibialis anterior allograft yield load in extremely low density tibiae. Arch Orthop Trauma Surg 2012; 132:343–347.

Back to Top | Article Outline

Pharmalogical treatment

Butler EE, Rose J. The Pediatric Upper Limb Motion Index and a temporal-spatial logistic regression: Quantitative analysis of upper limb movement disorders during the Reach & Grasp Cycle. J Biomech 2012; 45:945–951.

Dalton EC, Pfile KR, Weniger GR, Ingersoll CD, et al. Neuromuscular Changes After Aerobic Exercise in People with Anterior Cruciate Ligament-Reconstructed Knees. J Athl Train 2011; 46:476–483.

Dong L, Donaldson A, Metzger R, Keenan H. Analgesic Administration in the Emergency Department for Children Requiring Hospitalization for Long-Bone Fracture. Pediatr Emerg Care 2012; 28:109–114.

Karnwal A, Liao W, Julka IS, Kakazu CZ. Stellate ganglion block for postoperative analgesia in patients with upper extremity orthopaedic injuries. Anaesthesia 2011; 66:1052–1053.

Kutilek S, Plasilova I, Nemec V. Once-monthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass. J Paediatr Child Health 2012; 48:622–623.

Li M, Xia WB, Xing XP, Yu W, et al. Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta. Chin Med J 2011; 124:3049–3053.

Martinez-Soto T, Pacaud D, Stephure D, Trussell R, et al. Treatment of symptomatic osteoporosis in children: a comparison of two pamidronate dosage regimens. J Pediatr Endocrinol Metab 2011; 24:271–274.

Mussa A, Porta F, Baldassarre G, Tuli G, et al. Phalangeal quantitative ultrasound in 1,719 children and adolescents with bone disorders. Osteoporosis Int 2012; 23:1987–1998.

Piatt JH, Grissom LE. Developmental anatomy of the atlas and axis in childhood by computed tomography. J Neurosurg-Pediatr 2011; 8:235–243.

Pitts SAB, Feldman HA, Dorale A, Gordon CM. Bone Mineral Density, Fracture, and Vitamin D in Adolescents and Young Women Using Depot Medroxyprogesterone Acetate. J Pediatr Adolesc Gynecol 2012; 25:23–26.

Rianthavorn P, Pisutikul K, Deekajorndech T, Tepmongkol S, et al. Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone. J Pediatr Endocrinol Metab 2012; 25:307–312.

Ross PA, Smith BM, Tolo VT, Khemani RG. Continuous Infusion of Bupivacaine Reduces Postoperative Morphine Use in Adolescent Idiopathic Scoliosis After Posterior Spine Fusion. Spine 2011; 36:1478–1483.

Sharma A, Tallchief D, Blood J, Kim T, et al. Perioperative Pharmacokinetics of Methadone in Adolescents. Anesthesiology 2011; 115:1153–1161.

Toplak N, Subelj V, Kveder T, Cucnik S, et al. Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2012; 30:436–444.

Back to Top | Article Outline

Burn injuries to children

Franz RW, Skytta CK, Shah KJ, Hartman JF, et al. A Five-Year Review of Management of Upper-Extremity Arterial Injuries at an Urban Level I Trauma Center. Ann Vasc Surg 2012; 26:655–664.

Ioncu A, Mader R, Bonin N, Ternamian PJ, et al. Bone-patellar tendon-bone graft via a single minimally-invasive approach versus a classical approach in anterior cruciate ligament reconstruction: A prospective study. Orthop Traumatol-Surg Res 2012; 98:426–431.

Ma B, Xi HJ, Wang JL, Yan Y, et al. Pediatric burns due to hot water from water dispenser: a neglected issue that should be highly concerned. Chin Med J 2012; 125:2053–2056.

Back to Top | Article Outline

Miscellaneous

Banerji A. Hereditary angioedema: Classification, pathogenesis, and diagnosis. Allergy & Asthma Proceedings 2011; 32:403–407.

Claudet I, Gurrera E, Marechal C, Cordier L, et al. Pediatric adder bites. Arch Pediatr 2011; 18:1278–1283.

Claudet I, Marechal C, Gurrera E, Cordier L, et al. Risk Factors for High-Grade Envenomations After French Viper Bites in Children. Pediatr Emerg Care 2012; 28:650–654.

Farr S, Grill F. Growth prognosis and surgical options for adolescents with tall stature. Monschr Kinderheilkd 2012; 160:387–392.

McCrone AB, Lillis K, Shaha SH. Snowboarding-Related Abdominal Trauma in Children. Pediatr Emerg Care 2012; 28:251–253.

Provance AJ, Engelman GH, Carty PM. Implications of Parental Influence on Child/Adolescent Helmet Use in Snow Sports. Clin J Sport Med 2012; 22:240–243.

Sajonz B, Madler B, Herberhold S, Paus S, et al. A case of tremor reduction and almost complete ageusia under bilateral thalamic (VIM) deep brain stimulation in essential tremor-a therapeutic dilemma. Acta Neurochir 2011; 153:2361–2363.

Villardo RJM, Rosas-Salazard C, Spahr JE, Dohar JE. An unusual solitary endobronchial pulmonary arteriovenous malformation in a 10 year-old child. Int J Pediatr Otorhinolaryngol 2011; 75:1463–1467.

Back to Top | Article Outline

Infectious diseases and immunization

Infectious disease issues in adoption of young children

Review: (pp. 78–87)

▪▪. Jones VF. Comprehensive health evaluation of the newly adopted child. Pediatrics 2012; 129:e214–e223. [18]

▪▪. Staat MA, Rice M, Donauer S, et al. Intestinal parasite screening in internationally adopted children: importance of multiple stool specimens. Pediatrics 2011; 128:e613–e622. [29]

Back to Top | Article Outline

Update on recent guidelines for the management of urinary tract infections in children: the shifting paradigm

Review: (pp. 88–94)

Akil I, Ozkinay F, Onay H, Canda E, et al. Assessment of Toll-like receptor-4 gene polymorphism on pyelonephritis and renal scar. Int J Immunogenet 2012; 39:303–307.

Ammenti A, Cataldi L, Chimenz R, Fanos V, et al. Febrile urinary tract infections in young children: recommendations for the diagnosis, treatment and follow-up. Acta Paediatr 2012; 101:451–457.

Andersen LB, Bank S, Hertz B, Soby KM, et al. Actinobaculum schaalii, a cause of urinary tract infections in children? Acta Paediatr 2012; 101:e232–e234.

Aslan S, Akil I, Aslan G, Onay H, et al. Vitamin D receptor gene polymorphism in children with urinary tract infection. Pediatr Nephrol 2012; 27:417–421.

▪. Beetz R. Evaluation and management of urinary tract infections in the neonate. Curr Opin Pediatr 2012; 24:205–211. [08]

Beetz R. Diagnosis and Management of feverish Urinary Tract Infections in Infancy and Early Childhood - AAP (American Academy of Pediatrics)-Guidelines. Aktuelle Urol 2012; 43:1–5.

Beetz R. Evaluation and management of urinary tract infections in the neonate. Curr Opin Pediatr 2012; 24:205–211.

▪. Beetz R, Westenfelder M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents 2011; 38:42–50. [23]

Beetz R, Westenfelder M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents 2011; 38:42–50.

Bhat RG, Katy TA, Place FC. Pediatric Urinary Tract Infections. Emerg Med Clin N Am 2011; 29:637.

▪▪. Bocquet N, Sergent Alaoui A, Jais JP, et al. Randomized trial of oral versus sequential IV/oral antibiotic for acute pyelonephritis in children. Pediatrics 2012; 129:e269–275. [24]

Chen CC, Wu LC, Li CY, Liu CK, et al. Non-adherence to antibiotic prescription guidelines in treating urinary tract infection of children: a population-based study in Taiwan. J Eval Clin Pract 2011; 17:1030–1035.

▪. Cheng CH, Hang JF, Tsau YK, Lin TY. Nephromegaly is a significant risk factor for renal scarring in children with first febrile urinary tract infections. J Urol 2011; 186:2353–2357. [18]

Cheng CH, Hang JF, Tsau YK, Lin TY. Nephromegaly is a Significant Risk Factor for Renal Scarring in Children With First Febrile Urinary Tract Infections. J Urol 2011; 186:2353–2357.

▪. Cheng CH, Lee YS, Tsau YK, Lin TY. Genetic polymorphisms and susceptibility to parenchymal renal infection among pediatric patients. Pediatr Infect Dis J 2011; 30:309–314. [15]

▪. Copp HL, Shapiro DJ, Hersh AL. National ambulatory antibiotic prescribing patterns for pediatric urinary tract infection, 1998–2007. Pediatrics 2011; 127:1027–1033. [01]

de Jong T, Klijn AJ, Vijverberg MAW. Lower Urinary Tract Dysfunction in Children. Eur Urol Suppl 2012; 11:10–15.

Finnell SME, Carroll AE, Downs SM. Technical Report-Diagnosis and Management of an Initial UTI in Febrile Infants and Young Children. Pediatrics 2011; 128:749–770.

Finnell SME, Downs SM, Roberts KB. An American response to the Italian guideline on urinary tract infections in young children. Acta Paediatr 2012; 101:446–448.

Giurici N, Pennesi M. Urinary tract infections in children and the risk of ESRF. Acta Paediatr 2012; 101:e196.

Goldman RD. Cranberry juice for urinary tract infection in children. Can Fam Phys 2012; 58:398–400.

Hirdes MMC, de Jong T, Dik P, Vijverberg MAW, et al. Urethral length in girls with lower urinary tract symptoms and forme fruste of female epispadias. J Pediatr Urol 2010; 6:372–375.

Hunziker. Incidence of Febrile Urinary Tract Infections in Children after Successful Endoscopic Treatment of Vesicoureteral Reflux: A Long-Term Follow-Up (vol 160, pg 1015, 2012). J Pediatr 2012; 161:175.

Hunziker M, Mohanan N, D'Asta F, Puri P. Incidence of Febrile Urinary Tract Infections in Children after Successful Endoscopic Treatment of Vesicoureteral Reflux: A Long-Term Follow-Up. J Pediatr 2012; 160:1015–1020.

Krahenbuhl JD, Beaulieu C, Gehri M. Evaluation of a novel in-vitro diagnostic device for the detection of urinary tract infections in diaper-wearing children - art. no. w13560. Swiss Med Wkly 2012; 142:5.

Kurzrock EA. Antibiotic Prophylaxis for Urinary Tract Infections in Children With Spina Bifida on Intermittent Catheterization EDITORIAL COMMENT. J Urol 2011; 186:2371.

Kyrklund K, Taskinen S, Rintala RJ, Pakarinen MP. Lower Urinary Tract Symptoms from Childhood to Adulthood: A Population Based Study of 594 Finnish Individuals 4 to 26 Years Old. J Urol 2012; 188:588–593.

▪. Lee YJ, Lee JH, Park YS. Risk factors for renal scar formation in infants with first episode of acute pyelonephritis: a prospective clinical study. J Urol 2012; 187:1032–1036. [19]

Leroy S, Romanello C, Smolkin V, Galetto-Lacour A, et al. Prediction of Moderate and High Grade Vesicoureteral Reflux After a First Febrile Urinary Tract Infection in Children: Construction and Internal Validation of a Clinical Decision Rule. J Urol 2012; 187:265–271.

Luciano R, Piga S, Federico L, Argentieri M, et al. Development of a score based on urinalysis to improve the management of urinary tract infection in children. Clin Chim Acta 2012; 413:478–482.

Lytzen R, Thorup J, Cortes D. Experience with the NICE Guidelines for Imaging Studies in Children with First Pyelonephritis. Eur J Pediatr Surg 2011; 21:283–286.

▪▪. Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med 2011; 365:239–250. [10]

Poey ME, Albini M, Saona G, Lavina M. Virulence profiles in uropathogenic Escherichia coli isolated from pregnant women and children with urinary tract abnormalities. Microb Pathog 2012; 52:292–301.

Pohl H. Nephromegaly is a Significant Risk Factor for Renal Scarring in Children With First Febrile Urinary Tract Infections EDITORIAL COMMENT. J Urol 2011; 186:2357–2358.

▪▪. Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595–610. [07]

Roberts KB, Downs SM, Finnell SME, Hellerstein S, et al. Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months. Pediatrics 2011; 128:595–610.

Round J, Fitzgerald AC, Hulme C, Lakhanpaul M, et al. Urinary tract infections in children and the risk of ESRF. Acta Paediatr 2012; 101:278–282.

▪▪. Salo J, Ikaheimo R, Tapiainen T, Uhari M. Childhood urinary tract infections as a cause of chronic kidney disease. Pediatrics 2011; 128:840–847. [16]

Salo J, Ikaheimo R, Tapiainen T, Uhari M. Childhood Urinary Tract Infections as a Cause of Chronic Kidney Disease. Pediatrics 2011; 128:840–847.

▪. Salo J, Uhari M, Helminen M, et al. Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo-controlled trial. Clin Infect Dis 2012; 54:340–346. [36]

Salo J, Uhari M, Helminen M, Korppi M, et al. Cranberry Juice for the Prevention of Recurrences of Urinary Tract Infections in Children: A Randomized Placebo-Controlled Trial. Clin Infect Dis 2012; 54:340–346.

Sandoval C, Sinaki B, Weiss R, Munoz J, et al. Urinary Tract Infections in Pediatric Oncology Patients with Fever and Neutropenia. Pediatr Hematol Oncol 2012; 29:68–72.

Schlager TA, Le Gallo R, Innes D, Hendley JO, et al. B Cell Infiltration and Lymphonodular Hyperplasia in Bladder Submucosa of Patients With Persistent Bacteriuria and Recurrent Urinary Tract Infections. J Urol 2011; 186:2359–2364.

▪▪. Schroeder AR, Abidari JM, Kirpekar R, et al. Impact of a more restrictive approach to urinary tract imaging after febrile urinary tract infection. Arch Pediatr Adolesc Med 2011; 165:1027–1032. [29]

▪. Storm DW, Koff SA, Horvath Jr DJ, et al. In vitro analysis of the bactericidal activity of Escherichia coli Nissle 1917 against pediatric uropathogens. J Urol 2011; 186: 1678–1683. [40]

Storm DW, Koff SA, Horvath DJ, Li BR, et al. In Vitro Analysis of the Bactericidal Activity of Escherichia Coli Nissle 1917 Against Pediatric Uropathogens. J Urol 2011; 186:1678–1683.

▪. Storm DW, Patel AS, Horvath Jr DJ, et al. Relationship among bacterial virulence, bladder dysfunction, vesicoureteral reflux and patterns of urinary tract infection in children. J Urol 2012; 188:236–241. [12]

Storm DW, Patel AS, Horvath DJ, Li BR, et al. Relationship Among Bacterial Virulence, Bladder Dysfunction, Vesicoureteral Reflux and Patterns of Urinary Tract Infection in Children. J Urol 2012; 188:236–241.

▪. Tratselas A, Iosifidis E, Ioannidou M, et al. Outcome of urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children. Pediatr Infect Dis J 2011; 30:707–710. [27]

Tsai JD, Huang CT, Lin PY, Chang JH, et al. Screening high-grade vesicoureteral reflux in young infants with a febrile urinary tract infection. Pediatr Nephrol 2012; 27:955–963.

▪. Tsai JD, Huang CT, Lin PY, et al. Screening high-grade vesicoureteral reflux in young infants with a febrile urinary tract infection. Pediatr Nephrol 2012; 27:955–963. [30]

Tullus K. Difficulties in diagnosing urinary tract infections in small children. Pediatr Nephrol 2011; 26:1923–1926.

Wadie GM, Moriarty KP. The impact of vesicoureteral reflux treatment on the incidence of urinary tract infection. Pediatr Nephrol 2012; 27:529–538.

Wang CH, Fang CC, Chen NC, Liu SSH, et al. Cranberry-Containing Products for Prevention of Urinary Tract Infections in Susceptible Populations A Systematic Review and Meta-analysis of Randomized Controlled Trials. Arch Intern Med 2012; 172:988–996.

Wilson G, Badarudeen S, Godwin A. Antibiotic screening of urine culture as a useful quality audit. J Infect Dev Ctries 2011; 5:299–302.

Yang SSD, Chiang IN, Lin CD, Chang SJ. Advances in non-surgical treatments for urinary tract infections in children. World J Urol 2012; 30:69–75.

Yilmaz A, Gedikbasi A, Sevketoglu E, Karyagar S, et al. Urine endothelin-1 levels as a predictor of renal scarring in children with urinary tract infections. Clin Nephrol 2012; 77:219–224.

▪. Zaffanello M, Tardivo S, Cataldi L, et al. Genetic susceptibility to renal scar formation after urinary tract infection: a systematic review and meta-analysis of candidate gene polymorphisms. Pediatr Nephrol 2011; 26:1017–1029. [20]

Zegers B, Uiterwaal C, Kimpen J, van Gool J, et al. Antibiotic Prophylaxis for Urinary Tract Infections in Children With Spina Bifida on Intermittent Catheterization. J Urol 2011; 186:2365–2370.

Zincir H, Erten ZK, Ozkan F, Sevig U, et al. Prevalence of Urinary Tract Infections and Its Risk Factors in Elementary School Students. UrolInt 2012; 88:194–197.

Back to Top | Article Outline

Chronic fatigue syndrome following infections in adolescents

Review: (pp. 95–102)

Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S, et al. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun 2012; 26:24–31.

▪. Broderick G, Katz BZ, Fletcher MA, et al. Cytokine expression profiles of immune imbalance in postmononucleosis chronic fatigue. J Transl Med 2012; 10:191. [78]

▪▪. Brown M, Bell DS, Jason LA, et al. Understanding long-term outcomes of chronic fatigue syndrome. J Clin Psychol (in press). [80]

Cassisi G, Sarzi-Puttini P, Cazzola M. Chronic widespread pain and fibromyalgia: could there be some relationship with infections and vaccinations? Clin Exp Rheumatol 2011; 29:S118–S126.

Galbraith S, Cameron B, Li H, Lau D, et al. Peripheral Blood Gene Expression in Postinfective Fatigue Syndrome Following From Three Different Triggering Infections. J Infect Dis 2011; 204:1632–1640.

Jammes Y, Steinberg JG, Delliaux S. Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins. J Intern Med 2012; 272:74–84.

▪▪. Katz BZ, Stewart JM, Shiraishi Y, et al. Autonomic symptoms at baseline and following infectious mononucleosis in a prospective cohort of adolescents. Arch Pediatr Adolesc Med 2011; 165:765–766. [76]

Komaroff AL, Cho TA. Role of Infection and Neurologic Dysfunction in Chronic Fatigue Syndrome. Semin Neurol 2011; 31:325–337.

Malaguarnera M, Vacante M, Bertino G, Neri S, et al. The Supplementation of Acetyl-L-Carnitine Decreases Fatigue and Increases Quality of Life in Patients with Hepatitis C Treated with Pegylated Interferon-alpha 2b Plus Ribavirin. J Interferon Cytokine Res 2011; 31:653–659.

Mohammad A, Carey JJ, Storan E, Scarry M, et al. Prevalence of Fibromyalgia Among Patients With Chronic Hepatitis C Infection Relationship to Viral Characteristics and Quality of Life. J Clin Gastroenterol 2012; 46:407–412.

▪▪. Moss-Morris R, Spence MJ, Hou R. The pathway from glandular fever to chronic fatigue syndrome: can the cognitive behavioural model provide the map? Psychol Med 2011; 41:1099–1107. doi: 10.1017/S003329171000139X [79]

Naess H, Nyland M, Hausken T, Follestad I, et al. Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence - art. no. 13. BMC Gastroenterol 2012; 12:8.

▪. Nihof SL, Bleijenberg G, Uiterwaal CSPM, et al. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomized controlled trial. Lancet 2012; 379:1412–1418. doi: 10.1016/S0140-6736(12)60025-7 [84]

Pant C, Deshpande A, Anderson MP, Sferra TJ. Clostridium difficile Infection Is Associated With Poor Outcomes in End-Stage Renal Disease. J Invest Med 2012; 60:529–532.

Strauss B, Loschau M, Seidel T, Stallmach A, et al. Are fatigue symptoms and chronic fatigue syndrome following Q fever infection related to psychosocial variables? J Psychosomat Res 2012; 72:300–304.

Yuan K, Park JK, Qubti MA, Haque UJ. Recurrent Kawasaki Disease With Strawberry Tongue and Skin Desquamation in a Young Adult. JCR-J Clin Rheumatol 2012; 18:96–98.

Back to Top | Article Outline

Advances in the treatment of Kawasaki disease

Review: (pp. 103–109)

Bosland A, Arlaud K, Rousset-Rouviere C, Fouilloux V, et al. Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empyema. Arch Pediatr 2011; 18:1310–1314.

Burns JC. Of Mice and Children Lessons From a Kawasaki Mouse Model. Circulation 2012; 125:1480–1481.

Cai ZH, Zuo RH, Liu YL. Characteristics of Kawasaki Disease in Older Children. Clin Pediatr 2011; 50:952–956.

Carbone I, Cannata D, Algeri E, Galea N, et al. Adolescent Kawasaki disease: usefulness of 64-slice CT coronary angiography for follow-up investigation. Pediatr Radiol 2011; 41:1165–1173.

Chahal N, Somji Z, Manlhiot C, Clarizia NA, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada. Pediatr Int 2012; 54:383–387.

Chen S, Lee Y, Crother TR, Fishbein M, et al. Marked Acceleration of Atherosclerosis After Lactobacillus casei-Induced Coronary Arteritis in a Mouse Model of Kawasaki Disease. Arterioscler Thromb Vasc Biol 2012; 32:E60–E71.

Cho SY, Kim Y, Cha SH, Suh JT, et al. Adjuvant Laboratory Marker of Kawasaki Disease; NT-pro-BNP or hs-CRP? Ann Clin Lab Sci 2011; 41:360–363.

Cruz-Olivo F, Garcia-Elorriaga G, Gonzalez-Bonilla C, del Rey-Pineda G, et al. Tumor Necrosis Factor-308 and Lymphotoxin+252 Polymorphisms in Mexican Children with Kawasaki Disease and Coronary Aneurysms. Arch Med Res 2011; 42:602–607.

De Rosa G, Cefalo MG, Marano R, Piastra M, et al. Delayed diagnosis of Kawasaki syndrome and thrombosis of a medium-sized aneurysm of the anterior descending coronary artery: case report and literature review. Rheumatol Int 2012; 32:809–814.

Diniz JC, Almeida RT, Aikawa NE, Sallum AME, et al. Kawasaki disease and juvenile systemic lupus erythematosus. Lupus 2012; 21:89–92.

▪. Dominguez SR, Anderson MS, Eladawy M, et al. Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease. Pediatr Infect Dis J 2012; 31:1217–1220. [31]

Domoto S, Nakano K, Kodera K, Asano R, et al. Histopathology of the Longest-Lived Saphenous Vein Graft in a Patient With Kawasaki Disease. Ann Thorac Surg 2012; 93:2065–2067.

Erikstrup LT, Danielsen TKL, Hall V, Olsen KEP, et al. Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates. Clin Microbiol Infect 2012; 18:E266–E272.

Falcini F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas - art. no. 17. Pediatr Rheumatol 2011; 9:20.

Goldberg E, Bishara J. Contemporary unconventional clinical use of co-trimoxazole. Clin Microbiol Infect 2012; 18:8–17.

Gorelik M, Wilson DC, Cloonan YK, Shulman ST, et al. Plasma Follistatin-Like Protein 1 is Elevated in Kawasaki Disease and May Predict Coronary Artery Aneurysm Formation. J Pediatr 2012; 161:116–119.

Gravel H, Dahdah N, Fournier A, Mathieu ME, et al. Ventricular Repolarisation During Exercise Challenge Occurring Late After Kawasaki Disease. Pediatr Cardiol 2012; 33:728–734.

Hensgens MPM, Keessen EC, Squire MM, Riley TV, et al. Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect 2012; 18:635–645.

Huang MY, Huang JJ, Huang TY, Gupta-Malhotra M, et al. Deterioration of cutaneous microcirculatory status of Kawasaki disease. Clin Rheumatol 2012; 31:847–852.

Jibiki T, Kato I, Shiohama T, Abe K, et al. Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease. Pediatr Int 2011; 53:729–735.

Kaneko K, Yoshimura K, Ohashi A, Kimata T, et al. Prediction of the Risk of Coronary Arterial Lesions in Kawasaki Disease by Brain Natriuretic Peptide. Pediatr Cardiol 2011; 32:1106–1109.

Karpathios T, Moustaki M, Yiallouros P, Sharifi F, et al. Severe Jaundice in Two Children with Kawasaki Disease: A Possible Association with Gilbert Syndrome. J Korean Med Sci 2012; 27:101–103.

Kemmotsu Y, Nakayama T, Matsuura H, Saji T. Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease - art. no. 28. Pediatr Rheumatol 2011; 9:14.

Khor CC, Davila S, Breunis WB, Lee YC, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nature Genet 2011; 43:1241.

Kim GB, Kim HS, Choi JY. Chronic total occlusion by stent fracture in Kawasaki disease: is recanalisation possible? Cardiol Young 2012; 22:232–234.

Kim JJ, Hong YM, Yun SW, Han MK, et al. Assessment of Risk Factors for Korean Children with Kawasaki Disease. Pediatr Cardiol 2012; 33:513–520.

▪▪. Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 2012; 379:1613–1620. [15]

Kobayashi T, Saji T, Otani T, Takeuchi K, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 2012; 379:1613–1620.

Kuo HC, Chang WC. Genetic polymorphisms in Kawasaki disease. Acta Pharmacol Sin 2011; 32:1193–1198.

Kuo HC, Lin YJ, Juo SHH, Hsu YW, et al. Lack of Association between ORAI1/CRACM1 Gene Polymorphisms and Kawasaki Disease in the Taiwanese Children. J Clin Immunol 2011; 31:650–655.

Kuo HC, Yang YL, Chuang JH, Tiao MM, et al. Inflammation-Induced Hepcidin is Associated with the Development of Anemia and Coronary Artery Lesions in Kawasaki Disease. J Clin Immunol 2012; 32:746–752.

Lee KY, Rhim JW, Kang JH. Kawasaki Disease: Laboratory Findings and an Immunopathogenesis on the Premise of a ‘‘Protein Homeostasis System’'. Yonsei Med J 2012; 53:262–275.

Lee Y, Schulte DJ, Shimada K, Chen S, et al. Interleukin-1 beta Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease. Circulation 2012; 125:1542.

Lee YC, Kuo HC, Chang JS, Chang LY, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nature Genet 2012; 44:522.

Li XH, Zhang CY, Wu JX, Zhang T. Changes in plasma hydrogen sulfide and nitric oxide levels and their clinical significance in children with Kawasaki disease. Chin Med J 2011; 124:3445–3449.

Ling XB, Lau K, Kanegaye JT, Pan Z, et al. A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses - art. no. 130. BMC Med 2011; 9:6.

Liu RX, Gao F, Huo JM, Yi QJ. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease. Platelets 2012; 23:11–16.

Liu RX, He B, Gao F, Liu Q, et al. Association of the Resistin Gene Promoter Region Polymorphism with Kawasaki Disease in Chinese Children - art. no. 356362. Mediat Inflamm 2012;56362.

Luca NJC, Yeung RSM. Epidemiology and Management of Kawasaki Disease. Drugs 2012; 72:1029–1038.

Machaira M, Tsolia M, Constantopoulos I, Garoufi A, et al. Incomplete kawasaki disease with intermittent fever and retropharyngeal inflammation. Pediatr Infect Dis J 2012; 31:417–418.

Maes M, Twisk FNM, Kubera M, Ringel K. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Increased interleukin-1, tumor necrosis factor-alpha, PMN-elastase, lysozyme and neopterin. J Affect Disord 2012; 136:933–939.

Mori M, Imagawa T, Hara R, Kikuchi M, et al. Efficacy and Limitation of Infliximab Treatment for Children with Kawasaki Disease Intractable to Intravenous Immunoglobulin Therapy: Report of an Open-label Case Series. J Rheumatol 2012; 39:864–867.

Muta H, Ishii M, Yashiro M, Uehara R, et al. Late Intravenous Immunoglobulin Treatment in Patients With Kawasaki Disease. Pediatrics 2012; 129:E291–E297.

Nakamura Y, Yashiro M, Uehara R, Sadakane A, et al. Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide Survey. J Epidemiol 2012; 22:216–221.

Natterer J, Perez MH, Di Bernardo S. Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction. Cardiol Young 2012; 22:349–352.

Neudorf U. Kawasaki disease in children and adolescents. Z Rheumatol 2011; 70:838.

Onouchi Y. Genetics of Kawasaki Disease - What We Know and Don't Know. Circ J 2012; 76:1581–1586.

Oyamada J, Toyono M, Shimada S, Aoki-Okazaki M, et al. Altered Central Aortic Elastic Properties in Kawasaki Disease are Related to Changes in Left Ventricular Geometry and Coronary Artery Aneurysm Formation. J Am Soc Echocardiogr 2012; 25:690–696.

Pitzer VE, Burgner D, Viboud C, Simonsen L, et al. Modelling seasonal variations in the age and incidence of Kawasaki disease to explore possible infectious aetiologies. Proc R Soc B-Biol Sci 2012; 279:2736–2743.

Pucci A, Martino S, Tibaldi M, Bartoloni G. Incomplete and Atypical Kawasaki Disease: A Clinicopathologic Paradox at High Risk of Sudden and Unexpected Infant Death. Pediatr Cardiol 2012; 33:802–805.

Rascher W, Neubert A. Reinfection of recurrent Urinary tract infections Benefit and Risk assessment of Nitrofurantoin in Children. Monschr Kinderheilkd 2012; 160:171–173.

Roh K, Lee SW, Yoo J. CT Analysis of Retropharyngeal Abnormality in Kawasaki Disease. Korean J Radiol 2011; 12:700–707.

Scuccimarri R. Kawasaki Disease. Pediatr Clin N Am 2012; 59:425.

Servel AC, Vincenti M, Darras JP, Lalande M, et al. Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis. Arch Pediatr 2012; 19:741–744.

▪. Son MB, Gauvreau K, Burns JC, et al. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr 2011; 158:644.e1–649.e1. [42]

▪▪. Son MB, Newburger JW. Management of Kawasaki disease: corticosteroids revisited. Lancet 2012; 379:1571–1572. [16]

Suzuki H, Terai M, Hamada H, Honda T, et al. Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin. Pediatr Infect Dis J 2011; 30:871–876.

Tacke CE, Kuipers IM, Groenink M, Spijkerboer AM, et al. Cardiac Magnetic Resonance Imaging for Noninvasive Assessment of Cardiovascular Disease During the Follow-Up of Patients With Kawasaki Disease. Circ-Cardiovasc Imaging 2011; 4:712–720.

Takahashi K, Oharaseki T, Yokouchi Y, Yamada H, et al. A Half-Century of Autopsy Results - Incidence of Pediatric Vasculitis Syndromes, Especially Kawasaki Disease. Circ J 2012; 76:964–970.

Takanashi J, Shirai K, Sugawara Y, Okamoto Y, et al. Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci 2012; 315:167–169.

▪. Tremoulet AH, Pancoast P, Franco A, et al. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr 2012; 161:506–512. [58]

Tremoulet AH, Devera G, Best BM, Jimenez-Fernandez S, et al. Increased incidence and severity of kawasaki disease among filipino-americans in san diego county. Pediatr Infect Dis J 2011; 30:909–911.

Turel O, Bornaun H, Hatipoglu N, Oztarhan K. Kawasaki Disease in Dizygotic Twins in Turkey. J Rheumatol 2011; 38:1812–1813.

Uehara R, Belay ED. Epidemiology of Kawasaki Disease in Asia, Europe, and the United States. J Epidemiol 2012; 22:79–85.

Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Parents with a history of Kawasaki disease whose child also had the same disease. Pediatr Int 2011; 53:511–514.

Yahata T, Suzuki C, Hamaoka A, Fujii M, et al. Dynamics of Reactive Oxygen Metabolites and Biological Antioxidant Potential in the Acute Stage of Kawasaki Disease. Circ J 2011; 75:2453–2459.

Yamamura K, Ihara K, Ikeda K, Nagata H, et al. Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease. Int J Immunogenet 2012; 39:119–125.

Yu Y, Sun K, Wang RF, Li YH, et al. Comparison Study of Echocardiography and Dual-Source CT in Diagnosis of Coronary Artery Aneurysm Due to Kawasaki Disease: Coronary Artery Disease. Echocardiography-J Cardiovasc Ultrasound Allied Tech 2011; 28:1025–1034.

Zhu BH, Lv HT, Sun L, Zhang JM, et al. A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease. Eur J Pediatr 2012; 171:571–578.

Back to Top | Article Outline

Newer antifungal agents

Review: (pp. 110–115)

▪. Arrieta AC, Maddison P, Groll AH. Safety of micafungin in pediatric clinical trials. Pediatr Infect Dis J 2011; 30:e97–e102. [45]

▪. Ascher SB, Smith PB, Watt K, et al. Antifungal therapy and outcomes in infants with invasive Candida infections. Pediatr Infect Dis J 2012; 31:439–443. [11]

▪▪. Blyth CC. HKPPOTBM: Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections. Cochrane Database Syst Rev 2010: CD006343. [14]

▪. Doby EH, Benjamin Jr DK, Blaschke AJ, et al. Therapeutic monitoring of Voriconazole in children less than three years of age. Pediatr Infect Dis J 2012; 31:632–635. [23]

Kahn AM, Budoff MJ, Daniels LB, Jimenez-Fernandez S, et al. Calcium Scoring in Patients With a History of Kawasaki Disease. JACC-Cardiovasc Imag 2012; 5:264–272.

Kett DH, Shorr AF, Reboli AC, Reisman AL, et al. Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis - art. no. R253. Crit Care 2011; 15:R253.

Kim SH, Yim DS, Choi SM, Kwon JC, et al. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. Int J Infect Dis 2011; 15:E753–E758.

▪▪. Pieper S, Kolve H, Gumbinger HG, et al. Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients. J Antimicrob Chemother 2012; 67:2717–2724. [24]

Pitman SK, Drew RH, Perfect JR. Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations. Expert Opin Emerg Drugs 2011; 16:559–586.

▪▪. Tragiannidis A, Dokos C, Lehrnbecher T, Groll AH. Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice. Drugs 2012; 72:685–704. [01]

▪. Welzen MEB, Brüggemann RJM, van den Berg JM, et al. A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease. Pediatr Infect Dis J 2011; 30:794–797. [34]

Back to Top | Article Outline

Recent trends in the epidemiology and treatment of C. difficile infection in children

Review: (pp. 116–121)

Ananthakrishnan AN. Detecting and Treating Clostridium Difficile Infections in Patients with Inflammatory Bowel Disease. Gastroenterol Clin North Am 2012; 41:339.

Ananthakrishnan AN, Binion DG. Impact of Clostridium difficile on inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2010; 4:589–600.

Bakken JS, Borody T, Brandt LJ, Brill JV, et al. Treating Clostridium difficile Infection With Fecal Microbiota Transplantation. Clin Gastroenterol Hepatol 2011; 9:1044–1049.

Barbut F, Yezli S, Otter JA. Activity in vitro of hydrogen peroxide vapour against Clostridium difficile spores. J Hosp Infect 2012; 80:85–87.

Bitsori M, Maraki S, Koukouraki S, Galanakis E. Pseudomonas Aeruginosa Urinary Tract Infection in Children: Risk Factors and Outcomes. J Urol 2012; 187:260–264.

Bull AL, Worth LJ, Richards MJ. Implementation of standardised surveillance for Clostridium difficile infections in Australia: initial report from the Victorian Healthcare Associated Infection Surveillance System. Intern Med J 2012; 42: 715–718.

Chen KT, Stephens DJ, Anderson E, Acton R, et al. Clostridium difficile infection in the pediatric surgery population. J Pediatr Surg 2012; 47:1385–1389.

Citak M, Backhaus M, Dogan A, Aach M, et al. Clostridium difficile-Associated Infections in a Septic Ward of a Level 1 Trauma Centre: An Analysis of 159 Patients. Z Orthop Unfallchir 2012; 150:62–66.

Dacheux C, Pruvost I, Herbaux B, Nectoux E. Clostridium difficile reactive arthritis in a 7-year-old child. Arch Pediatr 2012; 19:607–611.

Ekma N, Yee LY, Aziz RA. Prevalence of Clostridium difficile infection in Asian countries. Rev Med Microbiol 2012; 23:1–4.

El-Herte RI, Baban TA, Kanj SS. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: A case report and review of the literature. Scand J Infect Dis 2012; 44:228–230.

Erikstrup LT, Danielsen TKL, Hall V, Olsen KEP, et al. Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates. Clin Microbiol Infect 2012; 18:E266–E272.

Goldberg E, Bishara J. Contemporary unconventional clinical use of co-trimoxazole. Clin Microbiol Infect 2012; 18:8–17.

Haverkate M, D'Ancona F, Johansen K, van der Velden K, et al. Assessing vaccination coverage in the European Union: is it still a challenge? Expert Rev Vaccines 2011; 10:1195–1205.

Hensgens MPM, Keessen EC, Squire MM, Riley TV, et al. Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect 2012; 18:635–645.

Huttunen R, Vuento R, Syrjanen J, Tissari P, et al. Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: a retrospective population-based study. Int J Infect Dis 2012; 16: E532–E535.

▪. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012; 107:1001–1010. [40]

Jorup-Ronstrom C, Hakanson A, Sandell S, Edvinsson O, et al. Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients. Scand J Gastroenterol 2012; 47:548–552.

Kato H, Kanematsu M, Kato Z, Teramoto T, et al. Computed Tomographic Findings of Kawasaki Disease With Cervical Lymphadenopathy. J Comput Assist Tomogr 2012; 36:138–142.

Kawada M, Annaka M, Kato H, Shibasaki S, et al. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection. J Infect Chemother 2011; 17:807–811.

Kee VR. Clostridium Difficile Infection in Older Adults: A Review and Update on Its Management. Am J Geriatr Pharmacother 2012; 10:14–24.

Kelly CR, de Leon L, Jasutkar N. Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients Methodology and Results. J Clin Gastroenterol 2012; 46:145–149.

Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol 2010; 4:409–416.

Kim YG, Graham DY, Jang BI. Proton Pump Inhibitor Use and Recurrent Clostridium difficile-associated Disease A Case-control Analysis Matched by Propensity Score. J Clin Gastroenterol 2012; 46:397–400.

Koene MGJ, Mevius D, Wagenaar JA, Harmanus C, et al. Clostridium difficile in Dutch animals: their presence, characteristics and similarities with human isolates. Clin Microbiol Infect 2012; 18:778–784.

Lancaster JW, Matthews SJ. Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections. Clin Ther 2012; 34:1–13.

Le F, Arora V, Shah DN, Salazar M, et al. A Real-World Evaluation of Oral Vancomycin for Severe Clostridium difficile Infection: Implications for Antibiotic Stewardship Programs. Pharmacotherapy 2012; 32:129–134.

Lee J, Tashjian DB, Moriarty KP. Is partial colectomy the operation of choice in pediatric Clostridium difficile colitis? Pediatr Surg Int 2012; 28:603–607.

Leonard AD, Ho KM, Flexman J. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study. Intern Med J 2012; 42:591–594.

Lo Vecchio A, Zacur GM. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol 2012; 28:1–9.

▪. Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364:422–431. [53]

Manque PA, Tenjo F, Woehlbier U, Lara AM, et al. Identification and Immunological Characterization of Three Potential Vaccinogens against Cryptosporidium Species. Clin Vaccine Immunol 2011; 18:1796–1802.

McCollum DL, Rodriguez JM. Detection, Treatment, and Prevention of Clostridium difficile Infection. Clin Gastroenterol Hepatol 2012; 10:581–592.

McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect 2012; 18:282–289.

Monge D, Morosini M, Milian I, Canosa CP, et al. Risk factors for Clostridium difficile infections in hospitalized patients. Med Clin 2011; 137:575–580.

Mora AL, Salazar M, Pablo-Caeiro J, Frost CP, et al. Moderate to High Use of Opioid Analgesics Are Associated With an Increased Risk of Clostridium difficile Infection. Am J Med Sci 2012; 343:277–280.

Navaneethan U, Mukewar S, Venkatesh PGK, Lopez R, et al. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. J Crohns Colitis 2012; 6:330–336.

▪. No Authors Given. Vital signs: preventing Clostridium difficile infections. Morb Mortal Wkly Rep 2012; 61:157–162. [06]

Onwueme K, Fadairo Y, Idoko L, Onuh J, et al. High prevalence of toxinogenic Clostridium difficile in Nigerian adult HIV patients. Trans Roy Soc Trop Med Hyg 2011; 105:667–669.

Orendi JM, Monnery DJ, Manzoor S, Hawkey PM. A two-stage algorithm for Clostridium difficile including PCR: can we replace the toxin EIA? J Hosp Infect 2012; 80:82–84.

Ota KV, McGowan KL. Clostridium difficile Testing Algorithms Using Glutamate Dehydrogenase Antigen and C. difficile Toxin Enzyme Immunoassays with C. difficile Nucleic Acid Amplification Testing Increase Diagnostic Yield in a Tertiary Pediatric Population. J Clin Microbiol 2012; 50:1185–1188.

Patel A, Gossett JJ, Benton T, Rowell E, et al. Fulminant Clostridium difficile toxic megacolon in a pediatric heart transplant recipient. Pediatr Transplant 2012; 16:E30–E34.

Rebeaud F, Bachmann MF. Immunization strategies for Clostridium difficile infections. Expert Rev Vaccines 2012; 11:469–479.

Rene P, Frenette CP, Schiller I, Dendukuri N, et al. Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type. Diagn Microbiol Infect Dis 2012; 73:94–96.

Ricciardi R, Nelson J, Griffith JL, Concannon TW. Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection? J Hosp Infect 2012; 80:156–161.

▪. Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011; 30:580–584. [25]

Selvaraju SB, Gripka M, Estes K, Nguyen A, et al. Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays. Diagn Microbiol Infect Dis 2011; 71:224–229.

Shah K, Pass LA, Cox M, Lanham M, et al. Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients. J Trauma Acute Care Surg 2012; 72:691–695.

Suissa D, De laney JAC, Dial S, Brassard P. Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease. Br J Clin Pharmacol 2012; 74:370–375.

Svensson AM, La Sala PR. Pathology Consultation on Detection of Clostridium difficile. Am J Clin Pathol 2012; 137:10–15.

Tschudin-Sutter S, Widmer AF, Perl TM. Clostridium difficile: novel insights on an incessantly challenging disease. Curr Opin Infect Dis 2012; 25:405–411.

Tsiouris A, Neale JA, Reickert CA, Times M. Clostridium Difficile of the Ileum Following Total Abdominal Colectomy, With or Without Proctectomy: Who Is at Risk? Dis Colon Rectum 2012; 55:424–428.

Vanek J, Hill K, Collins J, Berrington A, et al. Epidemiological survey of Clostridium difficile ribotypes in the North East of England during an 18-month period. J Hosp Infect 2012; 81:209–212.

Venugopal AA, Riederer K, Patel SM, Szpunar S, et al. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting. Scand J Infect Dis 2012; 44:243–249.

Warren CA, Labio E, Destura R, Sevilleja JE, et al. Clostridium difficile and Entamoeba histolytica infections in patients with colitis in the Philippines. Trans Roy Soc Trop Med Hyg 2012; 106:424–428.

Whitman CB, Czosnowski QA. Fidaxomicin for the Treatment of Clostridium difficile infections. Ann Pharmacother 2012; 46:219–228.

Wiegand PN, Nathwani D, Wilcox MH, Stephens J, et al. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 2012; 81:1–14.

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins